{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":1786,"total_is_capped":false,"direct_labels_cover":5,"predictions_cover":1786,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"query_hash":"87c7d6d6763a","filters":{"topic":"Systemic Sclerosis and Related Diseases"}},"results":[{"id":"W2508060872","doi":"10.1002/art.38098","title":"2013 Classification Criteria for Systemic Sclerosis: An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative","year":2013,"lang":"en","type":"article","venue":"Arthritis & Rheumatism","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":3406,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University; McGill University; Toronto Western Hospital; Jewish General Hospital; St Joseph's Health Care; University of Toronto; Mount Sinai Hospital","funders":"National Center for Advancing Translational Sciences; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Canadian Institutes of Health Research; University of Oxford; Gilead Sciences; Genentech; GlaxoSmithKline; Pfizer","keywords":"Medicine; Rheumatism; Rheumatology; Internal medicine; Scleroderma (fungus); Dermatology; Physical therapy; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.03500384499969365,"gpt":0.2735314758133565,"spread":0.2385276308136628,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000633578,0.0004774916,0.00139925,0.0003431773,0.0003164296,0.0000767335,0.0002974968,0.000204153,0.0002311046],"category_scores_gemma":[0.0004027804,0.0004401144,0.0002361684,0.0006545614,0.0006590334,0.0007028657,0.00005764659,0.0002259038,0.000261228],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001335526,"about_ca_system_score_gemma":0.0002857757,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007074525,"about_ca_topic_score_gemma":0.0000863454,"domain_scores_codex":[0.9956633,0.0008170179,0.001761268,0.0007347397,0.0004494454,0.0005741923],"domain_scores_gemma":[0.995832,0.0004348662,0.001258999,0.0007791237,0.001240754,0.000454256],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.0006712518,0.002493437,0.03138224,0.002258392,0.002098088,0.0000510075,0.01972125,0.00005995774,0.2087614,0.01365345,0.2116286,0.507221],"study_design_scores_gemma":[0.02662486,0.005259865,0.6584737,0.1769118,0.0005155706,0.001807229,0.1069714,0.01486469,0.004117295,0.001344143,0.0005908738,0.00251855],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9726202,0.01903554,0.0008295251,0.00141791,0.0004359244,0.003553555,0.0009096557,0.0002493901,0.0009482601],"genre_scores_gemma":[0.9403706,0.05481045,0.002819396,0.0003273679,0.00003723019,0.000994183,0.0004606585,0.0001172874,0.00006288863],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6270915,"threshold_uncertainty_score":0.9998051,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2164096595","doi":"10.1136/annrheumdis-2013-204424","title":"2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative","year":2013,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":2876,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University; McGill University; Toronto Western Hospital; Jewish General Hospital; St Joseph's Health Care; University of Toronto; Mount Sinai Hospital","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; Canadian Institutes of Health Research","keywords":"Medicine; Rheumatism; Rheumatology; Internal medicine; Scleroderma (fungus); Dermatology; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.08095854744517135,"gpt":0.3199430099495822,"spread":0.2389844625044109,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004385268,0.0003336041,0.00112002,0.0001933905,0.0001856947,0.00003176391,0.000443444,0.0000873443,0.00007571093],"category_scores_gemma":[0.001059388,0.0002239665,0.0003880919,0.0005969108,0.0007097039,0.000336335,0.00007258473,0.00009733956,0.00003843491],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003768839,"about_ca_system_score_gemma":0.0003162792,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002081774,"about_ca_topic_score_gemma":0.000005526617,"domain_scores_codex":[0.9965401,0.0008677511,0.00140142,0.0003956592,0.0004403245,0.0003547594],"domain_scores_gemma":[0.9951201,0.0005816032,0.001668957,0.0008875375,0.00141941,0.000322402],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"observational","study_design_scores_codex":[0.002927315,0.01056299,0.109004,0.02041907,0.009059492,0.000009719382,0.0172765,0.0004569702,0.0601952,0.01106861,0.6120527,0.1469674],"study_design_scores_gemma":[0.004411192,0.001307136,0.8740095,0.05788817,0.0009472388,0.00006439737,0.04774019,0.008432643,0.003293141,0.001164966,0.00006157958,0.0006798002],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9859468,0.006322684,0.0001011966,0.002852756,0.0002217572,0.002821195,0.001363734,0.00007732638,0.0002925313],"genre_scores_gemma":[0.9913722,0.007195689,0.0002681951,0.0004384437,0.00001938939,0.000444855,0.0001391282,0.00006187692,0.00006021709],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7650055,"threshold_uncertainty_score":0.913309,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2498506084","doi":"10.1016/s2213-2600(16)30152-7","title":"Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial","year":2016,"lang":"en","type":"article","venue":"The Lancet Respiratory Medicine","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":1062,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Heart, Lung, and Blood Institute","keywords":"Medicine; Cyclophosphamide; Mycophenolate; Placebo; Interstitial lung disease; Clinical endpoint; Internal medicine; Mycophenolic acid; Scleroderma (fungus); Surgery; Gastroenterology; Randomized controlled trial; Lung; Chemotherapy; Transplantation; Immunology; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.08201599126809177,"gpt":0.3333444022781768,"spread":0.251328411010085,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002730583,0.0005896444,0.002211294,0.0003154078,0.0002649306,0.0000267762,0.0005258087,0.0002676096,0.00105091],"category_scores_gemma":[0.001589476,0.0002733768,0.0004434739,0.0005529639,0.0006934827,0.0001827614,0.00015172,0.0005908809,0.00008775051],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003252622,"about_ca_system_score_gemma":0.0003353257,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001537495,"about_ca_topic_score_gemma":0.00003356173,"domain_scores_codex":[0.9949562,0.0007158748,0.001725156,0.0007493276,0.0009496721,0.0009037683],"domain_scores_gemma":[0.9962735,0.001134548,0.0005740142,0.00114996,0.0001626251,0.0007053933],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9797242,0.0003694263,0.001302093,0.00009224656,0.0007414688,0.0003133339,0.0003997507,0.00004376973,0.002633401,0.0006348679,0.01183643,0.001909047],"study_design_scores_gemma":[0.9844384,0.001414862,0.004583223,0.004326565,0.001314615,0.00001330856,0.0001895958,0.0003270282,0.00003914876,0.0001351282,0.00285094,0.0003671371],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.950245,0.02423322,0.0001015126,0.01069885,0.003481257,0.007152857,0.00002195616,0.0002678015,0.003797557],"genre_scores_gemma":[0.9906206,0.001968062,0.00001218535,0.002413671,0.003136477,0.001005428,0.0000333297,0.00007972508,0.0007305679],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04037558,"threshold_uncertainty_score":0.9999719,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4211149849","doi":"10.1038/nrdp.2015.2","title":"Systemic sclerosis","year":2015,"lang":"en","type":"review","venue":"Nature Reviews Disease Primers","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":862,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St Joseph's Health Centre","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","keywords":"Medicine; Disease; Autoimmunity; Autoantibody; Autoimmune disease; Pathogenesis; Fibrosis; Immunology; Scleroderma (fungus); Multiple sclerosis; Pathology; Antibody","retraction":null,"screen_n_in":null,"score":{"opus":0.1266469131859163,"gpt":0.3906108913228414,"spread":0.2639639781369251,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001117162,0.001250064,0.00659214,0.0004755911,0.000111704,0.00007466193,0.0005624015,0.001822236,0.0002488963],"category_scores_gemma":[0.0009675452,0.0007750893,0.003861851,0.001188154,0.0001253288,0.0001027492,0.0001589876,0.002062871,0.002650888],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009111116,"about_ca_system_score_gemma":0.002790674,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000003693645,"about_ca_topic_score_gemma":1.068403e-7,"domain_scores_codex":[0.9941691,0.0008086232,0.002026133,0.001271945,0.001054882,0.0006693169],"domain_scores_gemma":[0.993989,0.0001203159,0.001279013,0.001928531,0.0003188792,0.002364258],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00003177418,0.0001570745,0.00001050153,0.1111628,0.0005775184,0.00006499157,0.00000823038,5.864255e-8,7.852736e-7,0.00003498305,0.07308462,0.8148667],"study_design_scores_gemma":[0.000399346,0.00002532443,0.00001055648,0.3472278,0.01639095,0.0001508546,0.000007608113,7.372832e-7,1.056494e-7,0.000002809659,0.6353096,0.0004743458],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000001881881,0.9891206,0.000002144069,0.00005194457,0.001498254,0.006981067,0.0002362515,0.000254726,0.001853126],"genre_scores_gemma":[0.00001433504,0.9947881,0.0001135638,0.0004810786,0.001068316,0.000919923,0.001079445,0.000230007,0.001305272],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8143923,"threshold_uncertainty_score":0.9994736,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2041443103","doi":"10.1001/jama.2014.6368","title":"Autologous Hematopoietic Stem Cell Transplantation vs Intravenous Pulse Cyclophosphamide in Diffuse Cutaneous Systemic Sclerosis","year":2014,"lang":"en","type":"article","venue":"JAMA","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":744,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Centre Hospitalier Universitaire de Bordeaux; Versus Arthritis; Julius-Maximilians-Universität Würzburg; Università degli Studi di Ferrara; Dipartimento di Medicina Sperimentale e Clinica, Università degli Studi di Firenze; Université de Montréal; Universiteit Leiden; Leids Universitair Medisch Centrum; Università degli Studi di Firenze; Vrije Universiteit Amsterdam; Radboud Universitair Medisch Centrum; KU Leuven; National Institute for Health and Care Research; University of Leeds; Radboud Universiteit; James Cook University","keywords":"Medicine; Cyclophosphamide; Hematopoietic stem cell transplantation; Transplantation; Internal medicine; Surgery; Clinical endpoint; Randomization; Clinical trial; Chemotherapy","retraction":null,"screen_n_in":null,"score":{"opus":0.01057091587892902,"gpt":0.2113891683838513,"spread":0.2008182525049222,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002459369,0.0002802057,0.0006346648,0.0001931943,0.00008058927,0.00005473383,0.0001574971,0.0003617549,0.00005348913],"category_scores_gemma":[0.00004142212,0.0002312854,0.0001569841,0.0002993678,0.00006131364,0.00007900228,0.00001819357,0.0003048549,0.0002165236],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001836958,"about_ca_system_score_gemma":0.0000801193,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002152602,"about_ca_topic_score_gemma":0.00001460158,"domain_scores_codex":[0.9978404,0.0001745957,0.0007063436,0.0004580425,0.0003751873,0.0004454421],"domain_scores_gemma":[0.9988003,0.0002230831,0.0001872256,0.0004465725,0.00007806855,0.0002647467],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.006809535,0.00747808,0.1498266,0.01812307,0.0004911482,0.005289483,0.02919233,0.001608559,0.3104955,0.0008070738,0.002872652,0.467006],"study_design_scores_gemma":[0.07106181,0.003630089,0.6660231,0.05885576,0.002937951,0.03021222,0.00790289,0.01161204,0.14388,0.0002455708,0.0007371356,0.002901421],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9919586,0.00418555,0.0002312585,0.0003146975,0.0004137414,0.0006951085,0.00002026824,0.000199594,0.001981176],"genre_scores_gemma":[0.9955512,0.003182343,0.00007639685,0.0004529031,0.0001615758,0.00007097792,0.00003979039,0.00005508114,0.000409725],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5161965,"threshold_uncertainty_score":0.9431545,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2118846800","doi":"10.1002/art.20676","title":"Digital ulcers in systemic sclerosis: Prevention by treatment with bosentan, an oral endothelin receptor antagonist","year":2004,"lang":"en","type":"article","venue":"Arthritis & Rheumatism","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":726,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal; Western University","funders":"National Center for Research Resources","keywords":"Bosentan; Medicine; Internal medicine; Endothelin receptor antagonist; Scleroderma (fungus); Placebo; Endothelin receptor; Gastroenterology; Clinical endpoint; Surgery; Randomized controlled trial; Receptor; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.01613395426366306,"gpt":0.24268793006937,"spread":0.226553975805707,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001175737,0.0002971494,0.0005358604,0.0001258294,0.0001171843,0.0001359562,0.00008386459,0.0001429326,0.0001268635],"category_scores_gemma":[0.00001647101,0.0002307311,0.0001205232,0.0002126903,0.0001124923,0.0004585342,0.00001430796,0.000117007,0.0001483944],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005072063,"about_ca_system_score_gemma":0.0002004191,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009457787,"about_ca_topic_score_gemma":0.0003593925,"domain_scores_codex":[0.9981176,0.00007291979,0.00060348,0.0004719366,0.0003527237,0.0003813709],"domain_scores_gemma":[0.9991142,0.00002386434,0.0001714281,0.0003526951,0.00004903935,0.0002887493],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0007116806,0.003409649,0.04958811,0.0001544857,0.0004220968,0.0001393519,0.002352577,0.00009552521,0.06860068,0.0002704513,0.0009291185,0.8733262],"study_design_scores_gemma":[0.253148,0.04092852,0.09850727,0.467586,0.0010074,0.009580377,0.03735141,0.0003980586,0.0822456,0.0008215462,0.003596393,0.004829397],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9681627,0.02937008,0.00009441358,0.0002485709,0.0001879368,0.001042313,0.0002128049,0.0001573464,0.0005238699],"genre_scores_gemma":[0.9645447,0.03393632,0.0002577377,0.00006418268,0.00004028449,0.0001920152,0.000443088,0.00005525833,0.0004664093],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8684969,"threshold_uncertainty_score":0.9408941,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2347093301","doi":"10.1016/s0140-6736(16)00232-4","title":"Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial","year":2016,"lang":"en","type":"article","venue":"The Lancet","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":669,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University; Jewish General Hospital","funders":"","keywords":"Medicine; Tocilizumab; Placebo; Clinical endpoint; Internal medicine; Adverse effect; Randomized controlled trial; Surgery; Gastroenterology; Rheumatoid arthritis","retraction":null,"screen_n_in":null,"score":{"opus":0.01890877836985061,"gpt":0.2576959600043293,"spread":0.2387871816344787,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006001323,0.000166977,0.001305701,0.00006732543,0.00004454252,0.000009729144,0.0001256282,0.0000924969,0.00004841682],"category_scores_gemma":[0.0004231558,0.00006440696,0.000120335,0.0001467944,0.0001442508,0.00003202761,0.00002158766,0.00009782023,0.000006817256],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006089106,"about_ca_system_score_gemma":0.00008781035,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005670943,"about_ca_topic_score_gemma":0.00001104016,"domain_scores_codex":[0.9984331,0.0002331395,0.0005828221,0.0002362106,0.0002620592,0.0002526695],"domain_scores_gemma":[0.9981466,0.000982482,0.0002592402,0.0004389827,0.00007580318,0.00009690563],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.982453,0.0003332256,0.0004916568,0.0001540426,0.0002212675,0.00003744888,0.0004258485,0.000003521379,0.006851385,0.00004446579,0.000211152,0.008773009],"study_design_scores_gemma":[0.9844292,0.001653457,0.001564851,0.01099673,0.0003347821,0.0002324244,0.0002187474,0.00007448451,0.0003684693,0.000006779046,0.0000174804,0.0001026292],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9886344,0.004798375,0.00002262158,0.0009697598,0.0001136578,0.004639205,0.00003676247,0.00004015505,0.0007450308],"genre_scores_gemma":[0.9957269,0.003561628,0.0000102964,0.00006975027,0.0002768487,0.0001578594,0.000003534757,0.00001752668,0.0001755832],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01084268,"threshold_uncertainty_score":0.262644,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2089255535","doi":"10.1002/art.24038","title":"Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: A twenty‐year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis","year":2008,"lang":"en","type":"article","venue":"Arthritis & Rheumatism","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":602,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; Centre Hospitalier Universitaire de Sherbrooke; Université de Sherbrooke; University of Calgary; Université de Montréal","funders":"","keywords":"Autoantibody; Medicine; Connective tissue disease; Pathology; Scleroderma (fungus); Immunopathology; Prospective cohort study; Internal medicine; Antibody; Autoimmune disease; Immunology; Disease","retraction":null,"screen_n_in":null,"score":{"opus":0.02115824707249917,"gpt":0.2447956478835016,"spread":0.2236374008110024,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004104171,0.000316856,0.001035564,0.0002240395,0.0002624718,0.0000291045,0.0001577633,0.0001294683,0.00000595717],"category_scores_gemma":[0.0002045204,0.0002029064,0.0001638892,0.0002759605,0.0002085133,0.0002067193,0.00007595054,0.0001001866,4.715875e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008150491,"about_ca_system_score_gemma":0.0001008025,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002387964,"about_ca_topic_score_gemma":0.00001315989,"domain_scores_codex":[0.9973181,0.000165221,0.001024044,0.0005053288,0.000705554,0.0002817924],"domain_scores_gemma":[0.9971041,0.000232057,0.001008333,0.0004641055,0.001064173,0.0001272425],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001820538,0.001645371,0.9236584,0.00204228,0.001307,9.326832e-7,0.03401909,0.00005630183,0.03296826,0.00002158917,0.00005740278,0.002402803],"study_design_scores_gemma":[0.01340028,0.006376609,0.8808083,0.058476,0.0005457141,0.00001074863,0.02170281,0.00006307503,0.01841352,0.000006047008,3.065529e-7,0.0001966018],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9749372,0.009454462,0.0005663381,0.00001453349,0.0001574422,0.01438029,0.0004392226,0.00004608492,0.000004443171],"genre_scores_gemma":[0.9962495,0.002273799,0.0003332178,0.000003734507,0.0000207418,0.0009951476,0.00005816113,0.00005791339,0.000007800521],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05643372,"threshold_uncertainty_score":0.8274285,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2782208928","doi":"10.1056/nejmoa1703327","title":"Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma","year":2018,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":589,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ottawa Hospital; University of Calgary","funders":"National Institute of Allergy and Infectious Diseases","keywords":"Scleroderma (fungus); Medicine; Hematopoietic stem cell transplantation; Cyclophosphamide; Immunosuppression; Transplantation; Stem cell; Autologous stem-cell transplantation; CD34; Immunology; Chemotherapy; Surgery; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.02730863335350928,"gpt":0.2779308613472871,"spread":0.2506222279937778,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000570927,0.0001472866,0.0004967562,0.0001748686,0.00007713797,0.000006511784,0.00008668796,0.0001113541,0.0002033355],"category_scores_gemma":[0.00009587297,0.00008699509,0.0001149109,0.0001436079,0.0001319915,0.00008191351,0.00000441062,0.0001813807,0.000009744114],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004437581,"about_ca_system_score_gemma":0.0002356529,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002343164,"about_ca_topic_score_gemma":0.000005357211,"domain_scores_codex":[0.9986196,0.00007370432,0.0006071199,0.0001358351,0.0003729383,0.0001907962],"domain_scores_gemma":[0.9983692,0.0002940838,0.0003947127,0.0001205303,0.0004812396,0.000340261],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.01205925,0.0002855129,0.01023851,0.0006930748,0.0006919869,0.000315807,0.01486896,0.00005178052,0.06164806,0.0001702822,0.1069421,0.7920347],"study_design_scores_gemma":[0.5267267,0.03363131,0.2528697,0.02219398,0.007891694,0.02770867,0.006411066,0.001022892,0.03618382,0.001684068,0.0828157,0.0008603833],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9742926,0.006560235,0.006512291,0.006197926,0.001603613,0.0004563268,0.00001309035,0.00002938018,0.004334588],"genre_scores_gemma":[0.9896311,0.001425762,0.0005934651,0.0007136157,0.006206287,0.000002181654,0.00001201586,0.00001973228,0.001395861],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7911743,"threshold_uncertainty_score":0.3547557,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2589893823","doi":"10.5301/jsrd.5000231","title":"Standardization of the Modified Rodnan Skin Score for Use in Clinical Trials of Systemic Sclerosis","year":2017,"lang":"en","type":"article","venue":"Journal of Scleroderma and Related Disorders","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":521,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University; McGill University; Jewish General Hospital","funders":"Chugai Pharmaceutical; Genentech; National Institutes of Health; Medac; Bristol-Myers Squibb; CSL Behring; Sanofi; Servier; Amgen; Pfizer; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Biogen; GlaxoSmithKline","keywords":"Medicine; Scleroderma (fungus); Clinical trial; Standardization; Measure (data warehouse); Progressive systemic sclerosis; Medical physics; Physical therapy; Internal medicine; Pathology; Computer science; Data mining","retraction":null,"screen_n_in":null,"score":{"opus":0.1385580157512169,"gpt":0.367146890203873,"spread":0.2285888744526562,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004302994,0.0001596985,0.001229247,0.0002023785,0.0001530893,0.00003912172,0.0002306693,0.0003536851,0.000007870418],"category_scores_gemma":[0.004488508,0.00009050973,0.0007715019,0.0001575548,0.0003562564,0.000237396,0.00004822407,0.000311477,1.76371e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003483174,"about_ca_system_score_gemma":0.0002401361,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000593508,"about_ca_topic_score_gemma":0.00001425482,"domain_scores_codex":[0.9958153,0.0004930245,0.002943353,0.0001823627,0.0003979617,0.0001680269],"domain_scores_gemma":[0.9944995,0.0006066567,0.0039343,0.0004284582,0.0003981015,0.0001329579],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.008067732,0.001849761,0.767078,0.001878206,0.003070986,0.000009788638,0.002397378,0.0089091,0.05220396,0.0006546114,0.00266085,0.1512197],"study_design_scores_gemma":[0.01936012,0.0004749649,0.9512483,0.02226163,0.001245448,0.00006944913,0.00108094,0.002045853,0.001690828,0.0003416978,0.00003276874,0.0001480403],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9886161,0.008315714,0.0006116268,0.0006778633,0.0007856958,0.0008570687,0.00004194754,0.000004590794,0.00008935844],"genre_scores_gemma":[0.979803,0.01995077,0.00007533925,0.00002767285,0.00006309018,0.000004890494,0.000003242241,0.0000212819,0.00005067663],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1841703,"threshold_uncertainty_score":0.5373488,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2999836819","doi":"10.1016/j.autrev.2020.102458","title":"Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud's phenomenon and systemic sclerosis","year":2020,"lang":"en","type":"review","venue":"Autoimmunity Reviews","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":500,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; Jewish General Hospital","funders":"Actelion Pharmaceuticals; Manchester Biomedical Research Centre; Medac; Italfarmaco; National Institute for Health and Care Research; Eli Lilly and Company; CSL Behring; F. Hoffmann-La Roche; Sanofi; Genentech; Galápagos; Amgen; Pfizer; GlaxoSmithKline; Acceleron; Bayer","keywords":"Medicine; RAYNAUD DISEASE; Dermatology; Scleroderma (fungus); Progressive systemic sclerosis; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.0797903484733163,"gpt":0.3430165426033302,"spread":0.2632261941300139,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00105963,0.0004272804,0.003903281,0.00009748058,0.0001345372,0.00002090159,0.0002415969,0.0002082791,0.00002846662],"category_scores_gemma":[0.0002300475,0.0002097193,0.0006133125,0.0003927862,0.0001714128,0.00005108736,0.00008569798,0.0003075167,0.000002191533],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001924779,"about_ca_system_score_gemma":0.0005473415,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002645139,"about_ca_topic_score_gemma":7.822712e-7,"domain_scores_codex":[0.9968939,0.0005139553,0.001690186,0.0003102864,0.0004088798,0.0001828122],"domain_scores_gemma":[0.9961338,0.0004840652,0.002164698,0.0008216064,0.0002979504,0.00009786449],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00004082769,0.0001390841,0.0005614081,0.123584,0.0008574916,1.656691e-7,0.0001773109,5.068873e-7,0.00001814514,0.00004615835,0.0002770917,0.8742978],"study_design_scores_gemma":[0.001602455,0.0006928546,0.004376639,0.27302,0.01058881,0.000006501287,0.0001350137,0.00001582035,0.000002351198,0.000001592397,0.7093124,0.0002455359],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0004205043,0.9902132,0.0002126279,0.00002161704,0.0001401387,0.008358541,0.0005320823,0.00001847417,0.00008283646],"genre_scores_gemma":[0.003835547,0.9948478,0.0003187852,0.00002730243,0.00003982504,0.000524768,0.0003213549,0.00005797564,0.00002657952],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8740523,"threshold_uncertainty_score":0.8552105,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2163154920","doi":"10.1136/ard.2010.130658","title":"Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial","year":2010,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":498,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St Joseph's Health Care","funders":"Actelion Pharmaceuticals; National Center for Research Resources","keywords":"Medicine; Bosentan; Placebo; Double blind; Scleroderma (fungus); Internal medicine; Randomized controlled trial; Dermatology; Physical therapy; Alternative medicine; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.06191764842758914,"gpt":0.3096306431814677,"spread":0.2477129947538785,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005164092,0.000388429,0.001476239,0.000120451,0.0001676444,0.00008071776,0.0004846598,0.0001770193,0.0001023736],"category_scores_gemma":[0.002009605,0.0001792903,0.001459753,0.0003813893,0.0002593208,0.0001170251,0.00007553285,0.0001409723,0.00004487745],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003812732,"about_ca_system_score_gemma":0.0003300429,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003040283,"about_ca_topic_score_gemma":0.000008968176,"domain_scores_codex":[0.9962429,0.0002707698,0.001922648,0.0004201403,0.0007932534,0.0003502206],"domain_scores_gemma":[0.9947179,0.002096341,0.001089049,0.001436074,0.000258458,0.0004022063],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.981031,0.001728913,0.0008259889,0.00009253773,0.003274871,0.000002213193,0.00138583,0.0001130646,0.001389262,0.00005375626,0.004267735,0.005834801],"study_design_scores_gemma":[0.9822923,0.0007966167,0.003466283,0.006265012,0.002680385,0.000009785742,0.001762923,0.0001546762,0.002163355,0.0001437668,0.00004129963,0.0002236237],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9788826,0.005779997,0.000001196211,0.0029873,0.001249424,0.009571752,0.0007230749,0.00006545859,0.0007391634],"genre_scores_gemma":[0.9968352,0.001576817,0.000006332556,0.0001195341,0.0001492497,0.0006160651,0.0001058509,0.00004175078,0.0005491694],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01795259,"threshold_uncertainty_score":0.7311247,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2149389714","doi":"10.1093/rheumatology/kei251","title":"Juvenile localized scleroderma: clinical and epidemiological features in 750 children. An international study","year":2005,"lang":"en","type":"article","venue":"Lara D. Veeken","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":446,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Morphea; Internal medicine; Family history; Epidemiology; Localized Scleroderma; Dermatology; Scleroderma (fungus); Rheumatology; Methotrexate; Connective tissue disease; Disease; Autoimmune disease; Pediatrics; Immunology; Biopsy; Fibrosis","retraction":null,"screen_n_in":null,"score":{"opus":0.04769517054389106,"gpt":0.3596874773591585,"spread":0.3119923068152675,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009410045,0.0001618911,0.0005444152,0.00008769298,0.00004718042,0.0000258147,0.0001504107,0.0002304913,0.0001511249],"category_scores_gemma":[0.0005044901,0.0001121742,0.0001097926,0.0001036829,0.0001228973,0.0001172115,0.0000802134,0.0003717361,0.00003132446],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003659741,"about_ca_system_score_gemma":0.00003749428,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00009510795,"about_ca_topic_score_gemma":0.00005023701,"domain_scores_codex":[0.9980727,0.0003582686,0.000650752,0.0004594635,0.0002359537,0.0002228923],"domain_scores_gemma":[0.9991533,0.0001652258,0.0000986538,0.0002929503,0.00004373713,0.0002461128],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0003330152,0.001650679,0.9856672,0.000004078056,0.0001070616,0.00002762989,0.0001607165,0.00002791664,0.00006292857,0.00006812639,0.001993862,0.009896846],"study_design_scores_gemma":[0.006622704,0.0003930471,0.9909677,0.000154162,0.00008326075,0.00008538421,0.0002248396,0.0005257375,0.00000902415,0.0000314382,0.0007784327,0.0001242675],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9944982,0.002357438,0.000009721639,0.001548273,0.0002131546,0.0006040927,0.00001310284,0.00007255674,0.0006834858],"genre_scores_gemma":[0.996448,0.0007463695,0.0003726016,0.001433116,0.0007306348,0.00002516227,0.00005877307,0.00001524998,0.000170038],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009772578,"threshold_uncertainty_score":0.457433,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2060309556","doi":"10.1002/1529-0131(200106)44:6<1351::aid-art227>3.0.co;2-i","title":"A randomized, controlled trial of methotrexate versus placebo in early diffuse scleroderma","year":2001,"lang":"en","type":"article","venue":"Arthritis & Rheumatism","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":429,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Royal University Hospital; University of Saskatchewan; McMaster University; Jewish General Hospital; University of Ottawa; University of Toronto; University of Manitoba; Western University","funders":"","keywords":"Medicine; DLCO; Placebo; Methotrexate; Internal medicine; Scleroderma (fungus); Diffusing capacity; Randomized controlled trial; Gastroenterology; Surgery; Pathology; Lung","retraction":null,"screen_n_in":null,"score":{"opus":0.02298852018863304,"gpt":0.2716792081032395,"spread":0.2486906879146064,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001425029,0.0002556815,0.002473994,0.0002926333,0.00005328145,0.00002856716,0.0001105948,0.0001952671,0.0003420614],"category_scores_gemma":[0.00170015,0.0001924196,0.0006218337,0.0002964577,0.0002000187,0.0001303114,0.00003416675,0.000210403,0.00006273472],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004360841,"about_ca_system_score_gemma":0.000105949,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008641146,"about_ca_topic_score_gemma":0.00007824489,"domain_scores_codex":[0.9966351,0.0007239894,0.001464051,0.0003218107,0.0004971203,0.0003579253],"domain_scores_gemma":[0.9971822,0.001687765,0.0004335566,0.0003935396,0.000102105,0.0002008412],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9729588,0.0006328122,0.0007672773,0.00002561971,0.0004534316,0.00007397943,0.0007895143,0.000009027041,0.0002904359,0.0004203484,0.0002026303,0.02337611],"study_design_scores_gemma":[0.9896443,0.0004568208,0.002387514,0.006039698,0.0002392733,0.00005157117,0.0001479432,0.0005988704,0.00007380822,0.0001543745,0.00002831557,0.0001775064],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9621218,0.02491955,0.0000564605,0.0003138558,0.0009437772,0.004980086,0.000006016918,0.00006990567,0.006588485],"genre_scores_gemma":[0.9408773,0.05777038,0.0001930489,0.00005545718,0.00007445625,0.0006616731,0.00001080556,0.00003227184,0.0003246066],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03285083,"threshold_uncertainty_score":0.7846645,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4239432044","doi":"10.1097/01.bor.0000245727.40630.c3","title":"Localized scleroderma","year":2006,"lang":"en","type":"review","venue":"Current Opinion in Rheumatology","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":377,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hospital for Sick Children; University of Toronto; SickKids Foundation","funders":"","keywords":"Medicine; Scleroderma (fungus); Dermatology; Methotrexate; Rheumatology; Localized Scleroderma; Epidemiology; Morphea; Systemic scleroderma; Internal medicine; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.139716900611011,"gpt":0.4160219415283968,"spread":0.2763050409173858,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002057783,0.0005128081,0.003248966,0.0006079642,0.0000439413,0.00001708998,0.0002157079,0.0007673763,0.0001706692],"category_scores_gemma":[0.00013436,0.0003804959,0.0006966061,0.000522027,0.0001455441,0.00003131511,0.00009112842,0.0007071341,0.000506839],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001894678,"about_ca_system_score_gemma":0.0005672698,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004774688,"about_ca_topic_score_gemma":3.547977e-7,"domain_scores_codex":[0.9966367,0.0003503778,0.00163564,0.0006517781,0.0002545383,0.0004709149],"domain_scores_gemma":[0.9984369,0.0002360308,0.0005290617,0.0005554493,0.00006036965,0.0001821456],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001656519,0.0003971913,0.001306774,0.2046752,0.0001126387,0.000005015914,0.00001561595,8.118215e-7,2.180282e-8,0.0005347504,0.07206526,0.7208702],"study_design_scores_gemma":[0.001092721,0.00002245492,0.00008568003,0.2820259,0.0002035442,0.0005724915,0.000006454652,0.00001906768,2.661032e-8,0.00001697297,0.7157131,0.0002415374],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00001527734,0.9869593,0.00003542196,0.00003835612,0.01144499,0.001160666,0.00003853469,0.0001129681,0.0001945156],"genre_scores_gemma":[0.00002161954,0.9981847,0.0000202895,0.000002870361,0.0001125079,0.0002814102,0.001247146,0.00006925943,0.00006017107],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.7206286,"threshold_uncertainty_score":0.9998647,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1988434078","doi":"10.1002/art.21264","title":"Localized scleroderma in childhood is not just a skin disease","year":2005,"lang":"en","type":"article","venue":"Arthritis & Rheumatism","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":366,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Episcleritis; Scleroderma (fungus); Dermatology; Juvenile rheumatoid arthritis; Anti-nuclear antibody; Xerophthalmia; Vasculitis; Juvenile dermatomyositis; Pathology; Connective tissue disease; Systemic disease; Uveitis; Disease; Scleritis; Internal medicine; Autoimmune disease","retraction":null,"screen_n_in":null,"score":{"opus":0.01534736811225722,"gpt":0.2485890169028455,"spread":0.2332416487905882,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0001897547,0.0002723446,0.000539885,0.0002111095,0.0001106708,0.00005259015,0.0001331054,0.000151806,0.001933004],"category_scores_gemma":[0.0001262528,0.0002492044,0.0002240499,0.000311359,0.0001063737,0.0002209455,0.0000580343,0.0002456892,0.0008640734],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009382056,"about_ca_system_score_gemma":0.0001678995,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002765553,"about_ca_topic_score_gemma":0.0001033831,"domain_scores_codex":[0.9977376,0.00008605829,0.0007269313,0.0004854469,0.0004866512,0.0004772647],"domain_scores_gemma":[0.9986716,0.00006508725,0.0001235299,0.0005297984,0.00005959307,0.0005504122],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.0002477829,0.001413439,0.02910142,0.0001285263,0.0001364338,0.0001802388,0.003767209,0.00007029275,0.0006748327,0.0004388919,0.03175928,0.9320816],"study_design_scores_gemma":[0.01748763,0.000109505,0.9492531,0.0220273,0.0001050299,0.0002170923,0.0004328174,0.001326026,0.001414097,0.000157085,0.006937101,0.0005331984],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9378061,0.05337964,0.00003775304,0.006227988,0.0002551079,0.0006704429,0.000070565,0.0001544546,0.001397979],"genre_scores_gemma":[0.9650947,0.02923956,0.0003391386,0.004625265,0.0001796463,0.00009833405,0.00005399618,0.00005106354,0.0003182532],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9315484,"threshold_uncertainty_score":0.999996,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2051302134","doi":"10.1097/00005792-200203000-00005","title":"Predicting Mortality in Systemic Sclerosis","year":2002,"lang":"en","type":"article","venue":"Medicine","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":359,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Hôpital Notre-Dame; Canadian Institutes of Health Research","funders":"","keywords":"Medicine; MEDLINE","retraction":null,"screen_n_in":null,"score":{"opus":0.08715509529923726,"gpt":0.2804785795703771,"spread":0.1933234842711398,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004798124,0.0001680611,0.0005145264,0.0002101269,0.00005585368,0.000005656332,0.00008843368,0.0001339922,0.001223438],"category_scores_gemma":[0.0003835918,0.0001152488,0.00007551142,0.0004983777,0.0001144752,0.00005228565,0.00002714826,0.000224348,0.0001233219],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001183213,"about_ca_system_score_gemma":0.00001653808,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004397305,"about_ca_topic_score_gemma":0.00001759361,"domain_scores_codex":[0.9982017,0.00006834703,0.0006053483,0.0003180157,0.0004634478,0.0003431113],"domain_scores_gemma":[0.999102,0.00008546644,0.0001143356,0.000398407,0.00006222389,0.0002375488],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00002218709,0.0001674262,0.969644,0.000272755,0.00007327129,0.00009045767,0.0009313932,0.00001049311,0.01848945,0.00003881925,0.004662511,0.005597299],"study_design_scores_gemma":[0.005048336,0.0002704838,0.9675125,0.01936229,0.000312905,0.0002823038,0.001641571,0.004666826,0.0004163504,0.00001379995,0.0003010564,0.0001715362],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9565759,0.02798427,0.000013802,0.001547292,0.0004567224,0.0004256546,0.000003380245,0.0001372543,0.01285568],"genre_scores_gemma":[0.9949284,0.003149553,0.00001390736,0.0005620786,0.0005449628,0.00003818658,0.00001005747,0.00002313024,0.000729789],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03835239,"threshold_uncertainty_score":0.9996896,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2118156816","doi":"10.3899/jrheum.100245","title":"Prevalence of Pulmonary Hypertension in Systemic Sclerosis in European Caucasians and Metaanalysis of 5 Studies","year":2010,"lang":"en","type":"review","venue":"The Journal of Rheumatology","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":330,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false},"ca_institutions":"","funders":"","keywords":"Medicine; DLCO; Internal medicine; Pulmonary hypertension; Cardiology; Interstitial lung disease; Scleroderma (fungus); Pulmonary function testing; Lung; Diffusing capacity; Pathology; Lung function","retraction":null,"screen_n_in":null,"score":{"opus":0.07849855480930455,"gpt":0.3141937684246048,"spread":0.2356952136153002,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002353514,0.0002462794,0.003823189,0.0007506756,0.00002136708,0.00000209234,0.0002707181,0.0002306818,0.000006892406],"category_scores_gemma":[0.0006537801,0.0001232605,0.000414381,0.000435911,0.000304564,0.00003769964,0.00009689981,0.0006513812,0.000001787312],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004851574,"about_ca_system_score_gemma":0.0001805916,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001009536,"about_ca_topic_score_gemma":0.00001338427,"domain_scores_codex":[0.9955312,0.001512284,0.00237474,0.0001585792,0.0002584751,0.0001647308],"domain_scores_gemma":[0.9959376,0.0009288454,0.002453375,0.0003557574,0.0002545925,0.00006984006],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0004143598,0.0007969054,0.1901481,0.2811216,0.005709676,0.0003964612,0.002741192,0.00001997014,0.001662516,0.00002614283,0.0001618625,0.5168012],"study_design_scores_gemma":[0.001453274,0.0002825307,0.02097896,0.8797183,0.0195987,0.07424812,0.002891749,0.00003382365,0.00001382797,0.00001119286,0.0005222428,0.0002472843],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.3107576,0.6888229,7.83383e-7,0.00003917856,0.0001337082,0.0002211709,0.000004628228,0.000001807488,0.00001815829],"genre_scores_gemma":[0.4093567,0.5905954,0.00001224498,0.000003607765,0.000005007113,0.000001821359,5.286122e-7,0.00001539864,0.000009331875],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.5985967,"threshold_uncertainty_score":0.5026416,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1518950845","doi":"10.1038/nrrheum.2014.53","title":"Fibrosis—a lethal component of systemic sclerosis","year":2014,"lang":"en","type":"review","venue":"Nature Reviews Rheumatology","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":301,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University Health Network; McGill University; Toronto Western Hospital; Shriners Hospitals for Children - Canada; Montreal Children's Hospital","funders":"National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research; National Institutes of Health","keywords":"Fibrosis; Myofibroblast; Medicine; Inflammation; Extracellular matrix; Connective tissue; Pathology; Fibroblast; Wound healing; Pericyte; Immunology; Biology; Cell biology; Endothelial stem cell","retraction":null,"screen_n_in":null,"score":{"opus":0.04972211779247396,"gpt":0.3432657443390655,"spread":0.2935436265465915,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00111157,0.000962563,0.01321788,0.0005138964,0.00007416959,0.00001560791,0.0005585386,0.003595266,0.0001978747],"category_scores_gemma":[0.000697258,0.0006007658,0.003169016,0.0006737346,0.0002166849,0.00003433592,0.0001574988,0.001965478,0.0006711937],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000223001,"about_ca_system_score_gemma":0.0004840958,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002323989,"about_ca_topic_score_gemma":7.146095e-7,"domain_scores_codex":[0.9928539,0.001385303,0.003787549,0.0009270732,0.000490409,0.000555741],"domain_scores_gemma":[0.9941419,0.000682725,0.003092882,0.001516275,0.0002139438,0.0003522275],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001889425,0.0001370914,0.00005248941,0.3096208,0.0006351093,0.0000102855,0.00002076247,7.841576e-8,0.00001822054,0.0004224158,0.01698591,0.6720779],"study_design_scores_gemma":[0.0004062308,0.00007214336,0.00001004755,0.434813,0.00288593,0.003534087,0.000006848276,0.000002015803,0.000002041431,0.000001852329,0.5579892,0.0002766448],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00006723039,0.9942716,0.00002892001,0.00003939471,0.001635264,0.003381133,0.00007269574,0.00009785516,0.0004059477],"genre_scores_gemma":[0.001198243,0.9973838,0.0001587285,0.0000792969,0.0001435434,0.0003628008,0.0003983043,0.0001317174,0.0001435593],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.6718013,"threshold_uncertainty_score":0.9996444,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2108325327","doi":"10.1002/1529-0131(200108)44:8<1841::aid-art322>3.0.co;2-8","title":"Calcium-channel blockers for Raynaud's phenomenon in systemic sclerosis","year":2001,"lang":"en","type":"review","venue":"Arthritis & Rheumatism","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":289,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ottawa Hospital; Western University","funders":"","keywords":"Medicine; Placebo; Nifedipine; Randomized controlled trial; Internal medicine; Confidence interval; Clinical trial; Meta-analysis; Strictly standardized mean difference; Physical therapy; Calcium; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.079583225112147,"gpt":0.3141692558326093,"spread":0.2345860307204623,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005901309,0.0008444765,0.004141881,0.0006867251,0.0001656738,0.00008587104,0.0003020613,0.0009158729,0.0002121045],"category_scores_gemma":[0.0001973351,0.0007227436,0.001166416,0.0007871955,0.0001158836,0.0001201497,0.00008214145,0.0005223324,0.0002834531],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000541217,"about_ca_system_score_gemma":0.0004830179,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003658596,"about_ca_topic_score_gemma":0.0000406523,"domain_scores_codex":[0.9952294,0.0002218054,0.002176664,0.0009825876,0.0004964052,0.0008931474],"domain_scores_gemma":[0.9974318,0.0004196593,0.0007527219,0.0008197784,0.0001312142,0.0004448489],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"systematic_review","study_design_scores_codex":[0.00002312882,0.0001913493,0.00001701831,0.01859183,0.0003939678,0.00006128337,0.000227193,0.000002090632,0.000007277461,0.00009434426,0.006079225,0.9743113],"study_design_scores_gemma":[0.004685251,0.0002472379,0.00003695801,0.823028,0.001024975,0.001485278,0.0003340962,0.0000497849,0.000002115956,0.00006071127,0.1682484,0.0007972056],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0004035828,0.9921562,0.0001087845,0.00007561607,0.001029557,0.005118717,0.0003051138,0.0001898162,0.0006126321],"genre_scores_gemma":[0.004168333,0.9915324,0.0001719394,0.00008166155,0.000283192,0.002349305,0.0005642233,0.0002321435,0.0006167383],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9735141,"threshold_uncertainty_score":0.9995224,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2008227366","doi":"10.1002/art.24249","title":"B cell depletion with rituximab in patients with diffuse cutaneous systemic sclerosis","year":2009,"lang":"en","type":"article","venue":"Arthritis & Rheumatism","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":284,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"National Center for Research Resources; National Institute of Arthritis and Musculoskeletal and Skin Diseases","keywords":"Rituximab; Medicine; Internal medicine; Adverse effect; Autoantibody; Gastroenterology; Rash; Surgery; Immunology; Antibody; Lymphoma","retraction":null,"screen_n_in":null,"score":{"opus":0.005656825572989247,"gpt":0.1796851675991064,"spread":0.1740283420261171,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008176356,0.0002790906,0.0005743756,0.0001854198,0.0001041226,0.00005296666,0.00009296252,0.0001467334,0.00007070448],"category_scores_gemma":[0.0000239301,0.0002016891,0.00006687825,0.0003247353,0.00006636528,0.0001673049,0.00001351912,0.0002089597,0.000102515],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001242964,"about_ca_system_score_gemma":0.00007139942,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002188134,"about_ca_topic_score_gemma":0.00004992671,"domain_scores_codex":[0.9980466,0.0000692673,0.0005048439,0.0004263716,0.0005478838,0.0004050391],"domain_scores_gemma":[0.9990031,0.00004531105,0.0001850677,0.0004143637,0.0001260457,0.0002261818],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001748488,0.00782044,0.7141402,0.0003172105,0.0001317153,0.0003969982,0.001622615,0.00009645225,0.00173309,0.0001567061,0.002054175,0.2697819],"study_design_scores_gemma":[0.04698458,0.002782777,0.8886551,0.05950021,0.0001126424,0.0007076587,0.0003353163,0.0001104184,0.0002550799,0.000030438,0.00002759583,0.0004982543],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9833381,0.01452714,0.0000975255,0.0001468855,0.00008637096,0.0009501594,0.00001748163,0.0001451511,0.000691178],"genre_scores_gemma":[0.9918231,0.007321803,0.0003541679,0.0002493902,0.00002292184,0.00004392752,0.00007605211,0.00004198245,0.00006668648],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2692837,"threshold_uncertainty_score":0.8224643,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2061067032","doi":"10.1053/sarh.2001.20268","title":"Systemic sclerosis in 3 US ethnic groups: A comparison of clinical, sociodemographic, serologic, and immunogenetic determinants","year":2001,"lang":"en","type":"article","venue":"Seminars in Arthritis and Rheumatism","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":282,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"National Center for Research Resources; National Institute of Arthritis and Musculoskeletal and Skin Diseases; University of Calgary","keywords":"Medicine; Serology; Autoantibody; Immunology; Prospective cohort study; Internal medicine; Retrospective cohort study; Human leukocyte antigen; Antibody; Antigen","retraction":null,"screen_n_in":null,"score":{"opus":0.06340736796910536,"gpt":0.351610777465616,"spread":0.2882034094965107,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009600304,0.0002266089,0.001229602,0.0002630018,0.00006879053,0.00001785012,0.00009229728,0.0004105775,0.00002885581],"category_scores_gemma":[0.0001620637,0.0001912901,0.0001295353,0.0003612044,0.000389655,0.00007512813,0.00008148083,0.0003399316,0.000003408622],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002212789,"about_ca_system_score_gemma":0.00004253872,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003552745,"about_ca_topic_score_gemma":0.0003471636,"domain_scores_codex":[0.9971402,0.0002604035,0.001602298,0.0004301205,0.0002294122,0.0003375649],"domain_scores_gemma":[0.9988315,0.0003077084,0.0003731645,0.0002795211,0.00004476287,0.0001633448],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00008199671,0.000195148,0.597663,0.0001307379,0.00002285949,0.00003203435,0.0007821025,0.00000296607,0.001068593,0.000007295512,0.0000426517,0.3999706],"study_design_scores_gemma":[0.004254191,0.0005042678,0.8816765,0.1098647,0.00003932852,0.0004704564,0.001939013,0.0009039855,0.00008185422,0.0000910716,0.000004199982,0.000170445],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.5599314,0.4395338,0.000001947582,0.00003738302,0.000121848,0.0003073007,0.000006360055,0.00001396297,0.00004601777],"genre_scores_gemma":[0.5194383,0.4803743,0.0000939088,0.00003402233,0.00001038155,0.00002492045,0.000003502169,0.00001121748,0.000009370789],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3998001,"threshold_uncertainty_score":0.7800584,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2009206983","doi":"10.1046/j.1440-1681.2000.03343.x","title":"Diversity Within Pericytes","year":2000,"lang":"en","type":"review","venue":"Clinical and Experimental Pharmacology and Physiology","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":273,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Prince Edward Island","funders":"","keywords":"Pericyte; Microvessel; Mural cell; Population; Pathology; Biology; Cell biology; Endothelial stem cell; Endothelium; Hydrostatic pressure; Medicine; Immunohistochemistry; Endocrinology","retraction":null,"screen_n_in":null,"score":{"opus":0.1165641387481441,"gpt":0.4488339410039033,"spread":0.3322698022557592,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001463041,0.0003187155,0.001869344,0.00005434531,0.0004055721,0.000004661577,0.00008902255,0.0006739878,0.0009146984],"category_scores_gemma":[0.0000122125,0.0002104803,0.0003751676,0.00006487776,0.001055945,0.00002856062,0.0005289582,0.0005402365,0.00006271102],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001415563,"about_ca_system_score_gemma":0.00006632508,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001328564,"about_ca_topic_score_gemma":8.256085e-8,"domain_scores_codex":[0.9981232,0.0003774794,0.0006310777,0.0005883767,0.00005734123,0.0002225177],"domain_scores_gemma":[0.9990322,0.0003230907,0.0001794028,0.0001222375,0.00001307173,0.0003299712],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002914042,0.003503483,0.001765645,0.01127544,0.004754642,0.0002328052,0.00106749,3.563157e-7,0.001214254,0.0001415229,0.01674435,0.956386],"study_design_scores_gemma":[0.004703128,0.001808684,0.001623738,0.004221165,0.005341132,0.0005472821,0.000221352,0.00001932847,0.0001117076,0.00007632224,0.9806933,0.0006328386],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.147381,0.8509989,3.207239e-8,0.00003003138,0.0008402859,0.0004045226,0.0000170186,0.00003360042,0.0002946035],"genre_scores_gemma":[0.03662909,0.9611731,0.000009606245,0.001081073,0.000704114,0.00004404684,0.00005814441,0.00001790583,0.000282933],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.963949,"threshold_uncertainty_score":0.9999986,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2121837363","doi":"10.1093/rheumatology/keq310","title":"Frequency and impact of symptoms experienced by patients with systemic sclerosis: results from a Canadian National Survey","year":2010,"lang":"en","type":"article","venue":"Lara D. Veeken","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":263,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"Montreal General Hospital; University of Toronto; Jewish General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Physical therapy; Activities of daily living; Systemic scleroderma; Internal medicine; Disease","retraction":null,"screen_n_in":null,"score":{"opus":0.01552450312541998,"gpt":0.2456310026158139,"spread":0.230106499490394,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002124204,0.0001549742,0.000296328,0.0001046813,0.00006714485,0.00002577781,0.0000975087,0.0001692006,0.00006235199],"category_scores_gemma":[0.0003540615,0.0001049166,0.00005602466,0.0001942631,0.00009909485,0.00009236128,0.00001287411,0.0001501358,0.000007227753],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00011984,"about_ca_system_score_gemma":0.000537766,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.2643717,"about_ca_topic_score_gemma":0.01684887,"domain_scores_codex":[0.9986675,0.00006042145,0.0003472807,0.0002976827,0.0004023122,0.0002247711],"domain_scores_gemma":[0.9986646,0.0001159223,0.0001641342,0.0002606091,0.0003695987,0.0004251893],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0002211294,0.00009172139,0.9692682,0.00001267246,0.0001650816,0.000001797598,0.0006040983,0.000001665701,0.02780922,0.000006257715,0.001566268,0.0002518773],"study_design_scores_gemma":[0.00381584,0.0002037621,0.9944527,0.0009118934,0.00004976124,0.000006212171,0.00009963809,0.00004020844,0.0002797438,0.000005494597,0.000006345802,0.0001284078],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9943395,0.000864032,0.000001050352,0.00002629701,0.0001395665,0.0003690818,0.00380144,0.00002176993,0.0004373009],"genre_scores_gemma":[0.9986814,0.00004512854,0.00003661213,0.00005511855,0.00005065373,0.00002245983,0.00105633,0.00001924677,0.00003309574],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2475228,"threshold_uncertainty_score":0.9402064,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2130839876","doi":"10.3899/jrheum.120725","title":"Serum Interleukin 6 Is Predictive of Early Functional Decline and Mortality in Interstitial Lung Disease Associated with Systemic Sclerosis","year":2013,"lang":"en","type":"article","venue":"The Journal of Rheumatology","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":262,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false},"ca_institutions":"","funders":"National Institute for Health and Care Research; Ministero dell’Istruzione, dell’Università e della Ricerca; Imperial College London; Versus Arthritis; Royal Brompton and Harefield NHS Foundation Trust; European Respiratory Society","keywords":"Medicine; DLCO; Vital capacity; Internal medicine; Interstitial lung disease; Gastroenterology; Cohort; Pulmonary function testing; Idiopathic pulmonary fibrosis; Scleroderma (fungus); Proportional hazards model; Diffusing capacity; Immunology; Lung; Lung function","retraction":null,"screen_n_in":null,"score":{"opus":0.01940611181538815,"gpt":0.241011563276006,"spread":0.2216054514606178,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004790554,0.0001286867,0.0005496948,0.0001577503,0.00003500745,0.00001004703,0.000105388,0.00009855548,0.00012107],"category_scores_gemma":[0.0002433493,0.00007075383,0.00009073038,0.0001528119,0.0002444489,0.0001228537,0.00005278099,0.0002650476,0.000002593335],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008989184,"about_ca_system_score_gemma":0.0001782489,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004313325,"about_ca_topic_score_gemma":0.00003755236,"domain_scores_codex":[0.998454,0.0002521643,0.0007332463,0.0001074969,0.0002917226,0.0001613953],"domain_scores_gemma":[0.9983856,0.0002983977,0.0006603147,0.0001452654,0.0003418763,0.0001685298],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001643225,0.0001499671,0.9952577,0.0001218037,0.0006389989,0.000007770449,0.0008903068,0.00004324048,0.0004888792,0.00001843326,0.0006086581,0.0001310091],"study_design_scores_gemma":[0.003110439,0.0004573851,0.9835948,0.008589874,0.0005380234,0.0008745654,0.001118702,0.001518314,0.00005890827,0.00007570667,2.983271e-7,0.00006296082],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9956383,0.003025146,0.0002035872,0.0005722106,0.0002135345,0.0002903682,0.00002428735,0.000008127276,0.00002444612],"genre_scores_gemma":[0.9988834,0.000950459,0.000006094189,0.0001052495,0.00001279116,0.000007162183,0.000003058237,0.00001225974,0.00001948323],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01166288,"threshold_uncertainty_score":0.2885257,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2766145635","doi":"10.1136/annrheumdis-2017-211682","title":"Safety and efficacy of subcutaneous tocilizumab in systemic sclerosis: results from the open-label period of a phase II randomised controlled trial (faSScinate)","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":258,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St Joseph's Health Care; Western University; Jewish General Hospital","funders":"Roche; U.S. Department of Veterans Affairs","keywords":"Tocilizumab; Medicine; Placebo; Adverse effect; Clinical endpoint; Internal medicine; Surgery; Clinical trial; Gastroenterology; Rheumatoid arthritis","retraction":null,"screen_n_in":null,"score":{"opus":0.07693841705835605,"gpt":0.3406726985918478,"spread":0.2637342815334918,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.001138136,0.0002632861,0.001967753,0.00006682301,0.0003447272,0.0000679325,0.0009793887,0.0001146123,0.00003471833],"category_scores_gemma":[0.009327824,0.0001316612,0.0004184576,0.0001223177,0.0005110145,0.0001227649,0.0003926293,0.0001184662,0.000001132243],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000022103,"about_ca_system_score_gemma":0.0003442277,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00117229,"about_ca_topic_score_gemma":0.00001993961,"domain_scores_codex":[0.9963236,0.0005567508,0.001990202,0.0003361896,0.000549597,0.0002436502],"domain_scores_gemma":[0.9935926,0.002180037,0.002261839,0.001552157,0.0002469976,0.0001663757],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9715037,0.004859036,0.0002848902,0.0003944199,0.001306531,0.00000990654,0.001785455,0.00002510032,0.002107122,0.00007937474,0.0006027568,0.01704167],"study_design_scores_gemma":[0.9523818,0.001546598,0.01532559,0.02649729,0.00144783,0.00001705487,0.001028921,0.000906347,0.000561413,0.0001363543,0.000003404293,0.0001474274],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9723753,0.01779048,9.203762e-7,0.001590426,0.000256561,0.006895152,0.0007232409,0.000011889,0.0003560895],"genre_scores_gemma":[0.9946989,0.004878916,0.000007199858,0.00006489125,0.00003747749,0.0001387678,0.00002272055,0.00002101676,0.000130084],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02610287,"threshold_uncertainty_score":0.999017,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2938026556","doi":"10.2147/clep.s191418","title":"&lt;p&gt;Epidemiology of systemic sclerosis and systemic sclerosis-associated interstitial lung disease&lt;/p&gt;","year":2019,"lang":"en","type":"article","venue":"Clinical Epidemiology","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":254,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"Merck KGaA","keywords":"Medicine; Interstitial lung disease; Epidemiology; Incidence (geometry); Population; Disease; Internal medicine; Demography; Lung; Environmental health","retraction":null,"screen_n_in":null,"score":{"opus":0.1224814928774025,"gpt":0.3730525082707414,"spread":0.250571015393339,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.01354431,0.0007319732,0.006100366,0.0003367773,0.0001501628,0.000008292338,0.0005411838,0.001831931,0.0003030685],"category_scores_gemma":[0.05046753,0.0005685873,0.001483941,0.0004357892,0.001386686,0.0001287682,0.0004175596,0.001005797,0.0003367228],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003238038,"about_ca_system_score_gemma":0.0004458819,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007183591,"about_ca_topic_score_gemma":0.000007925476,"domain_scores_codex":[0.9823684,0.007510671,0.006649626,0.001788932,0.0003395411,0.001342833],"domain_scores_gemma":[0.9663573,0.02702871,0.003054315,0.001533853,0.0004730776,0.00155277],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00152845,0.0005417686,0.9676312,0.001540163,0.001230788,0.00002171108,0.00008727911,0.0001299495,0.01055213,0.004209161,0.01001837,0.00250901],"study_design_scores_gemma":[0.00682494,0.001139084,0.9443257,0.03425909,0.001697118,0.0002257516,0.0001727421,0.01015062,0.00001820952,0.0004274122,0.0001583247,0.0006009409],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8835,0.1087518,0.0004111671,0.001565025,0.003317062,0.00162537,0.0001709432,0.0002352597,0.0004233569],"genre_scores_gemma":[0.9593475,0.03581358,0.0001726645,0.003010099,0.0007018546,0.0001220033,0.0002103336,0.0001003248,0.0005216023],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07584751,"threshold_uncertainty_score":0.9996766,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2042096696","doi":"10.1378/chest.13-2626","title":"Predictors of Mortality and Progression in Scleroderma-Associated Interstitial Lung Disease","year":2014,"lang":"en","type":"review","venue":"CHEST Journal","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":253,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Interstitial lung disease; Internal medicine; Honeycombing; DLCO; Confounding; Diffusing capacity; Lung","retraction":null,"screen_n_in":null,"score":{"opus":0.06717998662726604,"gpt":0.3741976263975369,"spread":0.3070176397702709,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006813064,0.0002978523,0.001659308,0.0002638023,0.00005539673,0.00003416496,0.0001239619,0.0003336936,0.00004280706],"category_scores_gemma":[0.000640485,0.0001911659,0.0004718808,0.0002001576,0.0001423008,0.00006180878,0.0000631906,0.0006870783,0.00000226733],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002347246,"about_ca_system_score_gemma":0.0005567271,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000006745114,"about_ca_topic_score_gemma":0.000001587763,"domain_scores_codex":[0.9976524,0.0003077172,0.001119703,0.0002613977,0.0004134067,0.0002454367],"domain_scores_gemma":[0.9981007,0.0001066751,0.0009244932,0.0002184855,0.0000994566,0.0005501827],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0001955307,0.00117602,0.3143915,0.1173135,0.002251331,0.0004973886,0.0002910212,0.000001564421,0.000007945086,0.000008402561,0.003858383,0.5600074],"study_design_scores_gemma":[0.00297146,0.0001867017,0.2261874,0.7111956,0.009428735,0.0003711351,0.0000561974,0.0001619013,0.000001668127,0.00001065418,0.0490034,0.0004250798],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.02529053,0.9733886,0.000007786248,0.00002212047,0.0005870496,0.0005451891,0.00003543331,0.00001852352,0.0001048208],"genre_scores_gemma":[0.06464642,0.9346894,0.000008013954,0.00001332045,0.0004878448,0.00001813324,0.00007013063,0.00003630449,0.00003045465],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.5938821,"threshold_uncertainty_score":0.7795519,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1978280209","doi":"10.1016/j.autrev.2012.05.011","title":"Autoantibodies in systemic sclerosis","year":2012,"lang":"en","type":"review","venue":"Autoimmunity Reviews","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":248,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"","keywords":"Autoantibody; Immunology; Pathogenesis; Autoimmunity; Medicine; Serology; Antibody","retraction":null,"screen_n_in":null,"score":{"opus":0.2862147352546294,"gpt":0.3833744103392617,"spread":0.09715967508463236,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002202161,0.0008938038,0.007312419,0.0005701189,0.0001342734,0.00004922468,0.000498272,0.0008630609,0.0003975816],"category_scores_gemma":[0.0003672613,0.0005794584,0.001982315,0.001099484,0.0001321554,0.0001383974,0.0002204018,0.001343331,0.003598802],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005247677,"about_ca_system_score_gemma":0.0004445992,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001578916,"about_ca_topic_score_gemma":0.000004356527,"domain_scores_codex":[0.9940353,0.00157604,0.002819636,0.0005141344,0.0003450632,0.0007098365],"domain_scores_gemma":[0.99642,0.0002593351,0.001183212,0.001783522,0.00007057374,0.0002833308],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000003369504,0.000224773,0.00008672046,0.1085209,0.0001943479,0.000009955741,0.0001108835,3.014213e-8,0.000006769696,0.00003078501,0.001012035,0.8897994],"study_design_scores_gemma":[0.0002396839,0.00002363465,0.000289728,0.3936397,0.003295809,0.0003698629,0.00002746496,6.697097e-7,1.935565e-7,9.255334e-7,0.6017902,0.0003221752],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00003444624,0.9918951,0.000001517407,0.00001594281,0.0007793134,0.004213996,0.00003282034,0.000163819,0.00286306],"genre_scores_gemma":[0.0001562154,0.9967805,0.00006582056,0.0000903455,0.0002571055,0.0006936643,0.0003307484,0.0001278144,0.001497746],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8894773,"threshold_uncertainty_score":0.9996657,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2804710412","doi":"10.1002/art.40560","title":"Treatment Algorithms for Systemic Sclerosis According to Experts","year":2018,"lang":"en","type":"article","venue":"Arthritis & Rheumatology","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":241,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Ottawa Hospital; University of Ottawa; Western University","funders":"","keywords":"Medicine; Scleroderma (fungus); Internal medicine; Angiotensin Receptor Blockers; Algorithm; Angiotensin-converting enzyme; Computer science; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.04768462605752374,"gpt":0.3027475891281441,"spread":0.2550629630706204,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001001525,0.0002410967,0.0007257648,0.0001774064,0.0002361819,0.00003061094,0.0001003563,0.0001992943,0.0001013748],"category_scores_gemma":[0.0001352456,0.0001948324,0.0002128127,0.0001885179,0.0001196778,0.00006059986,0.00003352012,0.00003897949,0.0003474654],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001462957,"about_ca_system_score_gemma":0.0001128189,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002784017,"about_ca_topic_score_gemma":0.00002965823,"domain_scores_codex":[0.9982357,0.00005256923,0.0005333729,0.0005124515,0.0001480259,0.0005178737],"domain_scores_gemma":[0.9987614,0.0001617152,0.000106637,0.0004134124,0.0002105685,0.0003462644],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001089592,0.0008244664,0.1171374,0.00025977,0.0009143934,0.0001393079,0.004887788,0.000004073179,0.06941432,0.00215122,0.03330649,0.7698712],"study_design_scores_gemma":[0.1541254,0.05885884,0.05368435,0.1414141,0.002383947,0.1449955,0.0799958,0.006163659,0.2222448,0.001060611,0.1280195,0.007053588],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9792402,0.01511786,0.001201038,0.001427179,0.001071487,0.001332756,0.00002062788,0.0002060318,0.0003827599],"genre_scores_gemma":[0.9911549,0.005746137,0.001396457,0.0004896655,0.0002098291,0.0007261331,0.00002483493,0.00004952094,0.0002025405],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7628176,"threshold_uncertainty_score":0.7945037,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2125733524","doi":"10.1126/scitranslmed.3000488","title":"Mutations in Fibrillin-1 Cause Congenital Scleroderma: Stiff Skin Syndrome","year":2010,"lang":"en","type":"article","venue":"Science Translational Medicine","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":240,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; Canadian Institutes of Health Research; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Howard Hughes Medical Institute","keywords":"Fibrillin; Scleroderma (fungus); Medicine; Localized Scleroderma; Marfan syndrome; Systemic scleroderma; Dermatology; Pathology; Immunology; Internal medicine; Fibrosis; Disease","retraction":null,"screen_n_in":null,"score":{"opus":0.02860098793181211,"gpt":0.3052163002897928,"spread":0.2766153123579807,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005367398,0.0001515519,0.0002813401,0.0005204413,0.0001759076,0.00001775672,0.0001634116,0.00008074758,0.0006629898],"category_scores_gemma":[0.0003693367,0.0001113178,0.00005794797,0.001249117,0.00150309,0.0002652036,0.00001074542,0.0003137452,0.00005353587],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002679954,"about_ca_system_score_gemma":0.0005537032,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001308881,"about_ca_topic_score_gemma":0.00009825374,"domain_scores_codex":[0.9978136,0.00002236169,0.0004668155,0.0003984493,0.0009731363,0.0003256586],"domain_scores_gemma":[0.9989568,0.0001901397,0.0000675986,0.0002531793,0.0001716792,0.0003606331],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.000141337,0.0004158108,0.2436773,0.00009467406,0.00009110654,0.0002781815,0.003577971,0.0003247062,0.7361892,0.005386264,0.0002426877,0.00958073],"study_design_scores_gemma":[0.002868394,0.0001125696,0.9914101,0.0004894163,0.0001047397,0.0007454013,0.0003711049,0.00177815,0.001430496,0.0004346063,0.0001084197,0.0001466342],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9885592,0.0005968127,0.00008864413,0.006075603,0.0007785339,0.0004320387,0.00002217985,0.00005234606,0.003394654],"genre_scores_gemma":[0.9988082,0.00003593523,0.0004570084,0.0002678091,0.0002155565,0.00002099836,0.00005325465,0.00001296459,0.0001282477],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7477328,"threshold_uncertainty_score":0.7259273,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3007003780","doi":"10.1183/13993003.02026-2019","title":"Predictors of progression in systemic sclerosis patients with interstitial lung disease","year":2020,"lang":"en","type":"review","venue":"European Respiratory Journal","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":239,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"Italfarmaco; CSL Behring; National Institute for Health and Care Research; Galápagos; U.S. Department of Veterans Affairs; Apellis Pharmaceuticals; Canadian Institutes of Health Research; Medac; Fonds Wetenschappelijk Onderzoek; Galecto; F. Hoffmann-La Roche; Sanofi; GlaxoSmithKline; Celgene; Actelion Pharmaceuticals; Pfizer; Biogen; Gilead Sciences; Bayer; Eli Lilly and Company; Bristol-Myers Squibb; AstraZeneca; Genentech; Vlaamse regering; British Lung Foundation; Boehringer Ingelheim; Amgen; Glenmark Pharmaceuticals; Acceleron","keywords":"Medicine; Interstitial lung disease; Lung; Disease; Scleroderma (fungus); Lung disease; Pathology; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.03970656383990692,"gpt":0.2912095682859131,"spread":0.2515030044460062,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005664044,0.0004979715,0.00173318,0.0005085766,0.00008284221,0.00005832897,0.0003382683,0.0001340756,0.00005880483],"category_scores_gemma":[0.0002629597,0.0002958358,0.000594337,0.0004683897,0.00012406,0.0001084788,0.0001235104,0.0009968429,0.00004225773],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003387024,"about_ca_system_score_gemma":0.0008856429,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":4.187077e-7,"about_ca_topic_score_gemma":8.833798e-8,"domain_scores_codex":[0.9953851,0.001313984,0.001687576,0.0004614712,0.0008346747,0.0003172653],"domain_scores_gemma":[0.9969996,0.00006101354,0.001460278,0.000392546,0.0002118383,0.0008747138],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"systematic_review","study_design_scores_codex":[0.00107534,0.0006968277,0.1053735,0.03625834,0.001032089,0.002346969,0.0002082542,0.000005332267,0.000008899849,0.000002159418,0.003648802,0.8493435],"study_design_scores_gemma":[0.003931001,0.0008304661,0.03287076,0.7705751,0.003578697,0.0001603548,0.00005270263,0.000004576621,8.206846e-7,8.278566e-8,0.1875769,0.0004184782],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01022432,0.9873487,0.000009220121,0.000006272429,0.0006001166,0.001276027,0.00008558355,0.00004426534,0.000405506],"genre_scores_gemma":[0.0292421,0.969561,0.00001281153,0.00006311123,0.0008717645,0.00001851766,0.00004576557,0.0001670844,0.00001780516],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8489251,"threshold_uncertainty_score":0.9999494,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2520379025","doi":"10.1136/annrheumdis-2016-209768","title":"The European Scleroderma Trials and Research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: derivation and validation of a preliminarily revised EUSTAR activity index","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":234,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St Joseph's Health Care; Western University; McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Task force; Scleroderma (fungus); Physical therapy; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.2124305034721688,"gpt":0.3903012544553823,"spread":0.1778707509832135,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.008328075,0.0002015298,0.0007342683,0.0001030674,0.0004763885,0.00005614615,0.0002879392,0.00007276744,0.000003801867],"category_scores_gemma":[0.009654031,0.00008665017,0.0002715803,0.0002202948,0.0004141251,0.0001882821,0.0001460678,0.00006688167,2.347415e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003571905,"about_ca_system_score_gemma":0.0002226668,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000223666,"about_ca_topic_score_gemma":0.000001681081,"domain_scores_codex":[0.995999,0.001749655,0.001090858,0.0002977858,0.0005792215,0.0002835229],"domain_scores_gemma":[0.990566,0.00665335,0.001205426,0.0006323294,0.0008215325,0.0001213494],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.009959417,0.0007710189,0.004030978,0.0159014,0.001772824,1.99078e-7,0.002578394,0.0000107088,0.40575,0.0002961096,0.004532977,0.554396],"study_design_scores_gemma":[0.007461445,0.0006329307,0.8217428,0.0682724,0.001343864,0.000006867368,0.002034756,0.001128851,0.09604738,0.0009633692,0.00009306461,0.0002722896],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9802682,0.008967833,0.003332735,0.00258124,0.00007859603,0.004536957,0.0002080492,0.00001573016,0.00001062355],"genre_scores_gemma":[0.9932472,0.00611393,0.00009978646,0.00002737674,0.00004881761,0.0003786431,0.000008650131,0.00003110776,0.00004448228],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8177118,"threshold_uncertainty_score":0.9986881,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2963254827","doi":"10.1002/art.41055","title":"Abatacept in Early Diffuse Cutaneous Systemic Sclerosis: Results of a Phase <scp>II</scp> Investigator‐Initiated, Multicenter, Double‐Blind, Randomized, Placebo‐Controlled Trial","year":2019,"lang":"en","type":"article","venue":"Arthritis & Rheumatology","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":224,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University Health Network; Western University; Mount Sinai Hospital","funders":"National Center for Advancing Translational Sciences; U.S. National Library of Medicine; National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute of Allergy and Infectious Diseases; Genentech; National Institutes of Health; Regeneron Pharmaceuticals; Kiniksa Pharmaceuticals; Cumberland Pharmaceuticals; University of Michigan; United Therapeutics Corporation; Gilead Sciences; Sanofi; Amgen; Pfizer; Bristol-Myers Squibb","keywords":"Placebo; Double blind; Medicine; Multiple sclerosis; Multicenter study; Internal medicine; Randomized controlled trial; Pathology; Immunology","retraction":null,"screen_n_in":null,"score":{"opus":0.02723608350363746,"gpt":0.2707733588221479,"spread":0.2435372753185104,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001354968,0.0006127779,0.00449547,0.0007282231,0.0001242902,0.00005033669,0.0003390854,0.0007370395,0.00004195846],"category_scores_gemma":[0.00486273,0.0005039879,0.0007979259,0.000495148,0.0005621082,0.000216302,0.0001456239,0.0005866764,0.0002718886],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001032766,"about_ca_system_score_gemma":0.0005053669,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001135131,"about_ca_topic_score_gemma":0.00008807273,"domain_scores_codex":[0.9927376,0.001189948,0.003570002,0.0009733259,0.0006304758,0.0008986644],"domain_scores_gemma":[0.9935149,0.00320443,0.00140036,0.0009288362,0.0002975213,0.0006539733],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9821098,0.003033918,0.003077678,0.0003354983,0.0009376719,0.0002661551,0.003919272,0.00001811388,0.004524764,0.0002633932,0.0007036117,0.0008101469],"study_design_scores_gemma":[0.9768891,0.001903597,0.00004251047,0.01531759,0.0004257808,0.001689293,0.00153025,0.0007197671,0.001169541,0.00002860209,0.00006427155,0.0002197194],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9515093,0.03299052,0.00000659528,0.0001723744,0.00188506,0.01212602,0.00009455643,0.0001860948,0.001029461],"genre_scores_gemma":[0.9789498,0.01891605,0.00005189716,0.0001602448,0.00006849815,0.001267833,0.0001309871,0.00008831478,0.0003663253],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02744053,"threshold_uncertainty_score":0.9997412,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2104276638","doi":"10.1093/rheumatology/keh390","title":"Calcium channel blockers for primary Raynaud's phenomenon: a meta-analysis","year":2004,"lang":"en","type":"review","venue":"Lara D. Veeken","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":223,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Arthritis Research Centre of Canada","funders":"","keywords":"Medicine; Nifedipine; Placebo; Randomization; Internal medicine; Confidence interval; Randomized controlled trial; Meta-analysis; Inclusion and exclusion criteria; Calcium","retraction":null,"screen_n_in":null,"score":{"opus":0.1349489140679757,"gpt":0.3497646383531701,"spread":0.2148157242851943,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0005231924,0.0008505628,0.008453452,0.0006669664,0.0001384466,0.00006329379,0.0003753645,0.0008043175,0.0004194477],"category_scores_gemma":[0.00008012156,0.0005506597,0.01131971,0.001278897,0.0000851682,0.00005423144,0.00009819995,0.0004267819,0.0001485936],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005043207,"about_ca_system_score_gemma":0.0008676432,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006130604,"about_ca_topic_score_gemma":0.000002276755,"domain_scores_codex":[0.996215,0.0001591212,0.001338502,0.001032205,0.0006105508,0.0006445841],"domain_scores_gemma":[0.997116,0.0002566061,0.0007550583,0.001208938,0.0001847727,0.0004786148],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.00009472791,0.000660182,0.000002999687,0.0709342,0.8614365,0.0001162769,0.000179234,0.00002213831,0.000002956959,0.00009523883,0.00694852,0.05950698],"study_design_scores_gemma":[0.0007091768,0.00008802697,0.000003673578,0.003194662,0.5486494,0.00004076701,0.00002466341,0.00000508924,7.422343e-7,0.000017175,0.4469108,0.0003558471],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000002216967,0.9935628,0.000304855,0.0002828582,0.0002992688,0.00343537,0.0007574167,0.0001481571,0.001207054],"genre_scores_gemma":[0.00003015625,0.9883565,0.0005237681,0.0004733556,0.0006665199,0.001714878,0.002229837,0.0001591081,0.005845933],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.4399622,"threshold_uncertainty_score":0.9996945,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2161913883","doi":"10.1016/s0022-3476(00)90056-8","title":"Methotrexate and corticosteroid therapy for pediatric localized scleroderma","year":2000,"lang":"en","type":"article","venue":"The Journal of Pediatrics","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":222,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Methotrexate; Methylprednisolone; Corticosteroid; Leukopenia; Tolerability; Placebo; Surgery; Chemotherapy; Internal medicine; Gastroenterology; Adverse effect","retraction":null,"screen_n_in":null,"score":{"opus":0.0287072827228768,"gpt":0.2823993461700847,"spread":0.2536920634472079,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009167396,0.0001320788,0.0003433293,0.0001267438,0.0001025464,0.00002347538,0.0001215252,0.00009048214,0.0001192437],"category_scores_gemma":[0.0001489298,0.00006979847,0.0001603169,0.0002566475,0.00004561267,0.00007310583,0.00001066817,0.0001919446,0.000008667907],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002250131,"about_ca_system_score_gemma":0.0001233889,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000004757454,"about_ca_topic_score_gemma":1.7123e-7,"domain_scores_codex":[0.9987028,0.0001315131,0.0005626177,0.00009169243,0.0003172267,0.0001941884],"domain_scores_gemma":[0.9985759,0.0004908526,0.0003425949,0.0001699964,0.0002211452,0.0001995648],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.02435893,0.001997143,0.2516186,0.001586159,0.0005449071,0.0001257132,0.005026976,0.0007201539,0.01130404,0.0000517759,0.1096249,0.5930407],"study_design_scores_gemma":[0.09251045,0.01141331,0.8291612,0.0007238794,0.02179591,0.006939447,0.002266763,0.001588846,0.00338975,0.001770052,0.02690535,0.001535091],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9325949,0.06559235,0.0003594322,0.0007359032,0.0002240863,0.0003514759,0.000007612874,0.00001258773,0.000121673],"genre_scores_gemma":[0.8149374,0.1819888,0.0005369336,0.0006335888,0.001557194,0.000003212154,0.000001549024,0.00002450155,0.0003168398],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5915056,"threshold_uncertainty_score":0.2846299,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2026535970","doi":"10.1002/1529-0131(200103)44:3<735::aid-anr125>3.0.co;2-f","title":"Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: Addition of severe nailfold capillaroscopy abnormalities markedly increases the sensitivity for limited scleroderma","year":2001,"lang":"en","type":"letter","venue":"Arthritis & Rheumatism","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":219,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal","funders":"","keywords":"Scleroderma (fungus); Rheumatology; Medicine; Dermatology; Internal medicine; RAYNAUD DISEASE; Sensitivity (control systems); Systemic scleroderma; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.03224336035486054,"gpt":0.2636829686455491,"spread":0.2314396082906886,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00128115,0.0005896602,0.001874324,0.000272811,0.0005231423,0.00004793502,0.0003191731,0.000628491,0.00006800958],"category_scores_gemma":[0.001130382,0.0004165549,0.0006274141,0.0004128587,0.0009935496,0.0001901464,0.00008201333,0.0005546777,0.000004447879],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001338659,"about_ca_system_score_gemma":0.0003639467,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001661293,"about_ca_topic_score_gemma":0.00006912248,"domain_scores_codex":[0.9948902,0.001194875,0.002003774,0.0006583685,0.0006189346,0.0006339089],"domain_scores_gemma":[0.9899561,0.005097911,0.002835346,0.001056514,0.0009566247,0.00009751906],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"systematic_review","study_design_scores_codex":[0.001044535,0.0001975049,0.001982673,0.005007838,0.0009166665,0.00002570836,0.0006542164,0.00001053416,0.004706023,0.0003745187,0.975988,0.009091731],"study_design_scores_gemma":[0.0246543,0.006963675,0.2285357,0.5928671,0.006537,0.03824047,0.05149645,0.01945691,0.003249554,0.001139769,0.02304982,0.003809282],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8809343,0.03064974,0.0004860838,0.06689166,0.0006649792,0.006636773,0.01349834,0.0001588529,0.00007923514],"genre_scores_gemma":[0.937573,0.04272418,0.0006857934,0.01314987,0.0003219881,0.001704534,0.003597473,0.0001381856,0.0001049715],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9529382,"threshold_uncertainty_score":0.9998286,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2114857739","doi":"10.1016/j.semarthrit.2008.06.002","title":"Determinants of Morbidity and Mortality of Systemic Sclerosis in Canada","year":2008,"lang":"en","type":"article","venue":"Seminars in Arthritis and Rheumatism","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":218,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Western University","funders":"","keywords":"Medicine; Cohort; Interstitial lung disease; Internal medicine; Scleroderma (fungus); Pulmonary hypertension; Rheumatology; Cohort study; Mortality rate; Anti-nuclear antibody; Surgery; Lung; Pathology; Autoantibody; Immunology; Antibody","retraction":null,"screen_n_in":null,"score":{"opus":0.02446674158408158,"gpt":0.2406775222800546,"spread":0.216210780695973,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002059007,0.000113034,0.0006034943,0.00009637913,0.00002861955,0.000002005703,0.00003983831,0.00008139201,0.00001477014],"category_scores_gemma":[0.00007653867,0.00009872269,0.00003119716,0.0001429543,0.0001534892,0.00004797006,0.00003496535,0.00009127167,1.912793e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006595218,"about_ca_system_score_gemma":0.0003080589,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.6223397,"about_ca_topic_score_gemma":0.3662804,"domain_scores_codex":[0.9987231,0.00005519691,0.0006567825,0.0001890542,0.0002161828,0.000159648],"domain_scores_gemma":[0.9994428,0.00008023481,0.0001755987,0.0001686283,0.00003414694,0.00009863466],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00001669042,0.0000497494,0.9179454,0.0003306493,0.00001080695,0.00008009688,0.0006440472,0.000003282767,0.00213926,0.000008034743,0.00009704297,0.07867492],"study_design_scores_gemma":[0.001389544,0.00005567566,0.8838093,0.1114345,0.00001081683,0.0004772823,0.0008594582,0.0002127355,0.001655594,0.00001464815,3.437403e-7,0.00008010017],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7818732,0.2177389,3.540043e-7,0.000008260026,0.00008101502,0.0001899149,0.00003821287,0.000003133364,0.00006696947],"genre_scores_gemma":[0.6124114,0.3875251,0.00003121988,0.000007349224,0.000003110984,0.000007138348,0.000001910912,0.00000524765,0.000007507092],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2560592,"threshold_uncertainty_score":0.6452833,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4323569048","doi":"10.1183/16000617.0210-2022","title":"Prevalence, imaging patterns and risk factors of interstitial lung disease in connective tissue disease: a systematic review and meta-analysis","year":2023,"lang":"en","type":"review","venue":"European Respiratory Review","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":215,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia Hospital; University of Calgary; University of Saskatchewan; Toronto Metropolitan University; University of British Columbia","funders":"Veracyte; F. Hoffmann-La Roche; AstraZeneca","keywords":"Medicine; Interstitial lung disease; CTD; Rheumatoid arthritis; Connective tissue disease; Internal medicine; Myositis; Mixed connective tissue disease; Usual interstitial pneumonia; Meta-analysis; Disease; Pathology; Lung; Autoimmune disease","retraction":null,"screen_n_in":null,"score":{"opus":0.1015792900631865,"gpt":0.3662961202750525,"spread":0.264716830211866,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002749017,0.0008810759,0.01123646,0.0006293378,0.00006904786,0.00004412064,0.0003289482,0.00006528552,0.0002629611],"category_scores_gemma":[0.002768212,0.0005292068,0.002729299,0.001253444,0.0001559103,0.0001040808,0.000290855,0.0004567811,0.0000440562],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001018141,"about_ca_system_score_gemma":0.0001935614,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002242846,"about_ca_topic_score_gemma":0.000002394014,"domain_scores_codex":[0.989053,0.00591126,0.003055441,0.001128703,0.0005247947,0.0003268],"domain_scores_gemma":[0.9948507,0.0006552304,0.002258883,0.001319203,0.0001651591,0.0007508316],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.00000482718,0.00005221882,0.002780431,0.9542426,0.04054807,0.0003043812,0.00002203235,1.659536e-7,1.478318e-8,0.000003514027,0.0002446033,0.001797165],"study_design_scores_gemma":[0.00009183639,0.00001620039,0.001138921,0.4901486,0.5039499,0.000004952759,0.000007225264,0.000002208713,8.49532e-9,1.950025e-7,0.004401946,0.0002379904],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00002701948,0.9895949,0.000008197338,0.00003063354,0.00004787618,0.008444196,0.001728293,0.00006942336,0.00004946755],"genre_scores_gemma":[0.0002205068,0.998286,0.000001831151,0.0004985727,0.00003983979,0.0004875004,0.0001294163,0.0001412129,0.0001950977],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.4640939,"threshold_uncertainty_score":0.9997159,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2126139459","doi":"10.1136/ard.2009.111906","title":"Major histocompatibility complex (MHC) class II alleles, haplotypes and epitopes which confer susceptibility or protection in systemic sclerosis: analyses in 1300 Caucasian, African-American and Hispanic cases and 1000 controls","year":2009,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":211,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"National Center for Research Resources; National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institutes of Health","keywords":"Haplotype; Linkage disequilibrium; Immunology; Allele; HLA-DRB1; Genetics; Medicine; Genotyping; Human leukocyte antigen; Major histocompatibility complex; Allele frequency; Genotype; Biology; Antigen; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.1208579817604287,"gpt":0.3416424558652623,"spread":0.2207844741048336,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004833833,0.0003433182,0.001285917,0.0002361373,0.0001730541,0.00005014859,0.0001456343,0.00009967925,0.00003969876],"category_scores_gemma":[0.001444391,0.0002139115,0.0001328518,0.0005489656,0.0005372127,0.000157239,0.0000945979,0.0001704703,8.219769e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009694036,"about_ca_system_score_gemma":0.0002180672,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004910973,"about_ca_topic_score_gemma":0.002380639,"domain_scores_codex":[0.9970902,0.0005802816,0.001032077,0.0005702485,0.0003669549,0.0003602405],"domain_scores_gemma":[0.9979207,0.0005118748,0.0005079613,0.0005601189,0.0002163873,0.0002829826],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.009231538,0.006773006,0.8207461,0.006882809,0.001245567,0.00005337358,0.005555404,0.0001811104,0.03473314,0.0003752508,0.001685359,0.1125373],"study_design_scores_gemma":[0.002406294,0.0009396903,0.9846683,0.006551849,0.0003684899,0.00008069055,0.002932052,0.001423529,0.0002076972,0.0001693094,0.00001517662,0.0002369902],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9734178,0.02106475,0.000003647381,0.003077136,0.00003372899,0.002219332,0.00009749521,0.00004615975,0.00003994431],"genre_scores_gemma":[0.9962844,0.00320305,0.00002365241,0.0002720922,0.00001943124,0.0001294928,0.00001151574,0.00001922531,0.00003718406],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1639221,"threshold_uncertainty_score":0.8723059,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2005374793","doi":"10.1002/art.22532","title":"Pulmonary involvement in systemic sclerosis: Associations with genetic, serologic, sociodemographic, and behavioral factors","year":2007,"lang":"en","type":"article","venue":"Arthritis Care & Research","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":209,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"National Center for Research Resources; National Institute of Arthritis and Musculoskeletal and Skin Diseases","keywords":"Medicine; Vital capacity; Internal medicine; DLCO; Pulmonary function testing; Idiopathic pulmonary fibrosis; Diffusing capacity; Serology; Autoantibody; Interstitial lung disease; Immunology; Lung","retraction":null,"screen_n_in":null,"score":{"opus":0.08299930400467972,"gpt":0.342874671978469,"spread":0.2598753679737893,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008811824,0.000187022,0.0003697005,0.000509801,0.0002977971,0.00006031247,0.0001105811,0.0002685725,0.00003832235],"category_scores_gemma":[0.00004230213,0.000147349,0.00008788243,0.0006920094,0.00028846,0.00008826019,0.0000891546,0.0005369863,0.00001350343],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003312753,"about_ca_system_score_gemma":0.0001772418,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001499411,"about_ca_topic_score_gemma":0.001570001,"domain_scores_codex":[0.9972138,0.0002115493,0.0004455314,0.0004720176,0.0009413364,0.0007157078],"domain_scores_gemma":[0.9986619,0.0001798825,0.00007296279,0.0002939998,0.0004524405,0.0003388072],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00007693023,0.0002355453,0.9645333,0.00009032732,0.00003758524,0.0003044991,0.003473039,0.000002543906,0.007145124,0.00002778066,0.00006770517,0.02400556],"study_design_scores_gemma":[0.001818826,0.0005728704,0.9455404,0.002186081,0.00003944008,0.00009049188,0.04889199,0.000006266581,0.0006567659,0.0000175162,0.00002405483,0.0001553227],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9325432,0.0656487,0.000004837575,0.0001171146,0.00006298648,0.0009927257,0.00003567587,0.00006234339,0.0005324825],"genre_scores_gemma":[0.9900112,0.009512688,0.00007293162,0.00005726285,0.0000775119,0.0001111626,0.0000879451,0.00003218746,0.00003710579],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05746807,"threshold_uncertainty_score":0.600872,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2087005537","doi":"10.1016/j.ajhg.2013.12.002","title":"Immunochip Analysis Identifies Multiple Susceptibility Loci for Systemic Sclerosis","year":2014,"lang":"en","type":"article","venue":"The American Journal of Human Genetics","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":208,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba; University of Saskatchewan; University of Alberta; McMaster University; Alberta Health Services; Moncton Hospital; Western University; Jewish General Hospital","funders":"National Center for Research Resources; National Center for Advancing Translational Sciences; National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute of Allergy and Infectious Diseases; Sociedad Española de Reumatología; National Institutes of Health; Versus Arthritis; European League Against Rheumatism","keywords":"Locus (genetics); Single-nucleotide polymorphism; Biology; Genetics; Human leukocyte antigen; Allele; Genetic association; Gene; Genotype; Antigen","retraction":null,"screen_n_in":null,"score":{"opus":0.03123000168186644,"gpt":0.2878585685177166,"spread":0.2566285668358502,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00116015,0.0001667021,0.0008081247,0.0002191611,0.0002251956,0.00005297774,0.0003331259,0.00004022956,0.00002785057],"category_scores_gemma":[0.0002093684,0.0001007928,0.0007642,0.0004579411,0.000418737,0.0000283235,0.00003394477,0.0001704619,0.000005984633],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007695791,"about_ca_system_score_gemma":0.00005858044,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004892721,"about_ca_topic_score_gemma":0.00001181443,"domain_scores_codex":[0.9980847,0.0002676796,0.0008459654,0.0001757689,0.0003869052,0.0002389748],"domain_scores_gemma":[0.9972506,0.0003456297,0.001137166,0.0005949357,0.0005111542,0.0001605326],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.001002153,0.0004244883,0.2844369,0.0002326627,0.006801683,0.000005372706,0.002327833,0.002738576,0.678614,0.00004396633,0.002651505,0.02072097],"study_design_scores_gemma":[0.003314742,0.003466424,0.953477,0.001144973,0.01258524,0.0002997617,0.008337735,0.002817564,0.01382873,0.0002668504,0.0001157521,0.0003452793],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9916794,0.005029056,0.002637619,0.0002248432,0.0001107312,0.0002681212,0.000007366492,0.00001575526,0.00002713861],"genre_scores_gemma":[0.9981934,0.0007085108,0.0003750548,0.0001992732,0.0003837565,0.000007215405,0.000008013684,0.00002558882,0.00009918209],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6690401,"threshold_uncertainty_score":0.411021,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2561079487","doi":"10.1002/art.40027","title":"Early Mortality in a Multinational Systemic Sclerosis Inception Cohort","year":2016,"lang":"en","type":"article","venue":"Arthritis & Rheumatology","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":202,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Jewish General Hospital","funders":"Medical Research Council; Actelion Pharmaceuticals; Instituto de Salud Carlos III; Canadian Institutes of Health Research; GlaxoSmithKline Australia; National Health and Medical Research Council; Pfizer; Arthritis Australia; Ministerio de Ciencia e Innovación; GlaxoSmithKline","keywords":"Medicine; Cohort; Interquartile range; Internal medicine; Standardized mortality ratio; Cohort study; Mortality rate; Cause of death; Proportional hazards model; Disease; Pediatrics","retraction":null,"screen_n_in":null,"score":{"opus":0.01915670132198995,"gpt":0.2544444572153113,"spread":0.2352877558933214,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003220654,0.0001533894,0.0005010139,0.0001868804,0.00005969739,0.00001134361,0.00008043745,0.0002258832,0.0003276303],"category_scores_gemma":[0.0002603622,0.0001111201,0.0001082166,0.0001890742,0.0001754144,0.000132366,0.00003741301,0.0001034458,0.000376279],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001307097,"about_ca_system_score_gemma":0.0001049225,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006771621,"about_ca_topic_score_gemma":0.0001197735,"domain_scores_codex":[0.9982184,0.000152727,0.0006496059,0.0003891819,0.0002730612,0.0003169802],"domain_scores_gemma":[0.9991331,0.0001624487,0.0001528196,0.0002840618,0.000124381,0.0001432546],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00005257884,0.0001329897,0.9668871,0.00004028881,0.00006777121,0.00002946383,0.0001270469,7.721546e-7,0.0117262,0.001223265,0.0002741677,0.01943843],"study_design_scores_gemma":[0.004247015,0.00008147467,0.985948,0.008212671,0.00002667404,0.0007366572,0.00009690272,0.00003077476,0.0003210481,0.000133671,0.0000277486,0.0001373909],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9926725,0.005381771,0.0001095456,0.0004302285,0.0003503878,0.0005063313,0.00002438398,0.0001047065,0.0004201377],"genre_scores_gemma":[0.990236,0.009315413,0.00005254436,0.00008499625,0.00002568771,0.0001701177,0.00002000823,0.0000196805,0.0000755853],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01930103,"threshold_uncertainty_score":0.4836431,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2011178910","doi":"10.1164/rccm.201403-0442oc","title":"Vascular Receptor Autoantibodies in Pulmonary Arterial Hypertension Associated with Systemic Sclerosis","year":2014,"lang":"en","type":"article","venue":"American Journal of Respiratory and Critical Care Medicine","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":197,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Medicine; Connective tissue disease; Autoantibody; Angiotensin II; Pathogenesis; Internal medicine; Pulmonary hypertension; Pathology; Endothelin receptor; Endocrinology; Receptor; Immunology; Autoimmune disease; Antibody; Disease","retraction":null,"screen_n_in":null,"score":{"opus":0.021420002713348,"gpt":0.2571190320492229,"spread":0.2356990293358749,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000749202,0.0002071662,0.001020084,0.0002596965,0.00008041099,0.00001330663,0.00008029683,0.00009632124,0.00003627457],"category_scores_gemma":[0.001852393,0.0001230637,0.000108465,0.0003348819,0.0009530765,0.00008874436,0.00001893579,0.0003388886,0.000002061617],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008847822,"about_ca_system_score_gemma":0.0001137942,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000024042,"about_ca_topic_score_gemma":0.000001950878,"domain_scores_codex":[0.9977942,0.0004305284,0.0006860426,0.000239163,0.0005811735,0.0002689459],"domain_scores_gemma":[0.9980506,0.0005047751,0.0002532001,0.0001860405,0.0005984291,0.0004069803],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.005160067,0.0009415544,0.4032249,0.001376277,0.0007246466,0.001451402,0.003282345,0.00002174325,0.3307365,0.0003853797,0.001376707,0.2513185],"study_design_scores_gemma":[0.01453156,0.02852958,0.8225846,0.08065664,0.00244428,0.002280829,0.04539127,0.000147987,0.001047193,0.00003561224,0.00166334,0.0006870969],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9787362,0.01970485,0.00006631511,0.000836289,0.000303631,0.0001340459,0.000003845319,0.00002055344,0.0001942646],"genre_scores_gemma":[0.9973587,0.0006528253,0.00005782369,0.001337818,0.0005550221,0.000004690978,0.000004667893,0.00002465583,0.00000374118],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4193597,"threshold_uncertainty_score":0.5018393,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4322418740","doi":"10.1038/s41584-023-00909-5","title":"State-of-the-art evidence in the treatment of systemic sclerosis","year":2023,"lang":"en","type":"review","venue":"Nature Reviews Rheumatology","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":191,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Jewish General Hospital; McGill University; Windsor Regional Hospital; St Joseph's Health Care; University of Toronto; Toronto Western Hospital; Mount Sinai Hospital; Western University","funders":"Samsung; Swedish Orphan Biovitrum; Scleroderma Society of Ontario; Servier; Horizon Therapeutics; Acceleron; Alexion Pharmaceuticals; Teva Pharmaceutical Industries; Mitsubishi Tanabe Pharma Corporation; Mallinckrodt Pharmaceuticals; Gilead Sciences; Sanofi; Ikaria; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb; GlaxoSmithKline","keywords":"Medicine; Nintedanib; Bosentan; Interstitial lung disease; Tocilizumab; Idiopathic pulmonary fibrosis; Rituximab; Pulmonary hypertension; Iloprost; Cyclophosphamide; Scleroderma (fungus); Combination therapy; Clinical trial; Azathioprine; Pulmonary fibrosis; Internal medicine; Fibrosis; Immunology; Endothelin receptor; Lung; Chemotherapy; Disease; Prostacyclin","retraction":null,"screen_n_in":null,"score":{"opus":0.1520843288233733,"gpt":0.3860871498278048,"spread":0.2340028210044315,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001194813,0.0005430591,0.006119153,0.0003029067,0.0000441379,0.000007869994,0.000662224,0.0009877984,0.00002212955],"category_scores_gemma":[0.001009831,0.0002180352,0.00197647,0.001604151,0.0001845754,0.00002814839,0.00005778386,0.0007803129,0.0001936551],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002622902,"about_ca_system_score_gemma":0.0005985398,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005460194,"about_ca_topic_score_gemma":0.00002372754,"domain_scores_codex":[0.994053,0.001886942,0.002764568,0.0005155741,0.0004390492,0.0003408673],"domain_scores_gemma":[0.9944853,0.00179975,0.002048011,0.001478325,0.0001135966,0.00007504069],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"systematic_review","study_design_scores_codex":[0.00001854982,0.0002634848,0.0005344056,0.1632939,0.0004506627,0.00001414842,0.0003254212,3.270643e-7,0.000003249813,0.00006680285,0.006284946,0.8287442],"study_design_scores_gemma":[0.000287171,0.0001310483,0.0001047931,0.5623447,0.001850827,0.0006822362,0.00003252337,9.949623e-7,0.000001859058,0.000004793363,0.4344376,0.0001215137],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0004321994,0.9927926,9.650087e-7,0.0001202895,0.0009153809,0.005627183,0.00004595072,0.00002393037,0.00004150761],"genre_scores_gemma":[0.0008111813,0.9979386,0.000009882129,0.00004051627,0.00002838191,0.0008291891,0.00003419789,0.00005467633,0.0002534297],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8286226,"threshold_uncertainty_score":0.8891219,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2065840402","doi":"10.1038/nature12614","title":"Integrin-modulating therapy prevents fibrosis and autoimmunity in mouse models of scleroderma","year":2013,"lang":"en","type":"article","venue":"Nature","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":191,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University","funders":"National Institute of General Medical Sciences; Scleroderma Research Foundation; Scleroderma Foundation; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Howard Hughes Medical Institute","keywords":"Fibrosis; Fibrillin; Pathogenesis; Immunology; Extracellular matrix; Biology; Autoimmunity; Cancer research; Medicine; Pathology; Immune system; Cell biology","retraction":null,"screen_n_in":null,"score":{"opus":0.02053017831294075,"gpt":0.2630753979237493,"spread":0.2425452196108086,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001159686,0.0001077873,0.0002507123,0.00009086066,0.00002812429,0.00001126536,0.00006821903,0.0006455499,0.00006167521],"category_scores_gemma":[0.00005951996,0.00007479272,0.0000577952,0.0001416718,0.00003852138,0.0001269823,0.00003552666,0.0008925317,0.000002486171],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002635273,"about_ca_system_score_gemma":0.00002910699,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003387366,"about_ca_topic_score_gemma":0.000002463889,"domain_scores_codex":[0.9992434,0.00005656337,0.0002433576,0.0001506824,0.0001750752,0.0001308765],"domain_scores_gemma":[0.9994968,0.00004989887,0.00008237426,0.000222325,0.00008155048,0.00006702387],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.0002601967,0.0008385056,0.1936612,0.0004771184,0.0002425343,0.000003773376,0.00325053,0.0003609254,0.6972668,0.000222205,0.002107464,0.1013087],"study_design_scores_gemma":[0.003335902,0.0001360743,0.949038,0.002706615,0.00002867546,0.00001271846,0.0006537195,0.01850975,0.0247151,0.0006586583,0.00003347958,0.0001713312],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.98397,0.0147783,0.000006144642,0.0002168608,0.00005221687,0.0004268402,0.000007257527,0.000027991,0.0005143817],"genre_scores_gemma":[0.9980766,0.0009840851,0.0003539195,0.0002498757,0.00002432506,0.00001944837,0.0000106293,0.00001478313,0.0002663988],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7553768,"threshold_uncertainty_score":0.4979072,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2046798079","doi":"10.3899/jrheum.091165","title":"Characteristics of Joint Involvement and Relationships with Systemic Inflammation in Systemic Sclerosis: Results from the EULAR Scleroderma Trial and Research Group (EUSTAR) Database","year":2010,"lang":"en","type":"article","venue":"The Journal of Rheumatology","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":190,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false},"ca_institutions":"","funders":"","keywords":"Medicine; Scleroderma (fungus); Systemic inflammation; Systemic scleroderma; Inflammation; Systemic disease; Physical therapy; Immunology; Dermatology; Internal medicine; Immunopathology; Disease","retraction":null,"screen_n_in":null,"score":{"opus":0.08039068090633167,"gpt":0.2802287941372241,"spread":0.1998381132308925,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006976624,0.0001339525,0.0005742856,0.0002251821,0.0001764278,0.00002761139,0.0001720737,0.0001659943,0.000004089557],"category_scores_gemma":[0.001897557,0.00006568857,0.00004070891,0.0002285904,0.000392186,0.0001243158,0.00008670937,0.001057319,0.000001455579],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004570414,"about_ca_system_score_gemma":0.0001884885,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000793567,"about_ca_topic_score_gemma":0.0001979602,"domain_scores_codex":[0.9963819,0.001341521,0.001420597,0.0001593435,0.000500353,0.0001963103],"domain_scores_gemma":[0.9960843,0.001932679,0.00104674,0.0004362531,0.000383184,0.0001168061],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.05781582,0.0003092835,0.6695538,0.0009901223,0.0006024478,0.00003820076,0.01385031,0.00002452805,0.2534583,0.001074895,0.0007144301,0.001567853],"study_design_scores_gemma":[0.0721658,0.001271999,0.8504004,0.0416433,0.0007875164,0.009391613,0.02160144,0.0009535024,0.001369521,0.0001672826,0.00002523478,0.0002223101],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9928479,0.004744406,0.00004299187,0.001194736,0.0002787991,0.0008266724,0.00005086646,0.000006187324,0.000007451195],"genre_scores_gemma":[0.9885222,0.01126699,0.0000754899,0.00001530801,0.00006471488,0.00001223639,0.00002533224,0.0000147844,0.000002997858],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2520888,"threshold_uncertainty_score":0.4593583,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3003611811","doi":"10.1172/jci131700","title":"Cytotoxic CD4+ T lymphocytes may induce endothelial cell apoptosis in systemic sclerosis","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Investigation","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":187,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Sherbrooke; Institute of Infection and Immunity","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Allergy and Infectious Diseases; National Institutes of Health","keywords":"Cytotoxic T cell; Immunology; CD8; Fibrosis; Apoptosis; Immune system; Biology; T cell; Pathogenesis; Scleroderma (fungus); Medicine; Cancer research; Pathology; In vitro","retraction":null,"screen_n_in":null,"score":{"opus":0.1309557769457165,"gpt":0.3386674251786355,"spread":0.207711648232919,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001359743,0.0001814221,0.0008977897,0.0001623397,0.00003839877,0.00003731835,0.0001785413,0.0003124487,0.0000486661],"category_scores_gemma":[0.002832227,0.0001353518,0.000436354,0.0004422388,0.0001364658,0.0002092914,0.00003279259,0.000588173,0.00007516437],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001308003,"about_ca_system_score_gemma":0.0007229811,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000020527,"about_ca_topic_score_gemma":5.214296e-7,"domain_scores_codex":[0.9959365,0.0003963742,0.002623983,0.0002539433,0.0005833731,0.0002058696],"domain_scores_gemma":[0.9968881,0.000530783,0.001385247,0.0001728889,0.0002677295,0.0007552482],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001102285,0.0004672604,0.2648035,0.0005301411,0.0001887363,0.00005027688,0.001190208,0.0002991731,0.7196825,0.00004621734,0.004938194,0.006701514],"study_design_scores_gemma":[0.02558452,0.0033781,0.4091947,0.01986753,0.001190392,0.0003040363,0.002545006,0.003203575,0.533542,0.0001874828,0.0004024019,0.0006001987],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9934143,0.001858586,0.00004296473,0.003415158,0.0007021485,0.0003016212,0.000007600259,0.00002626995,0.000231315],"genre_scores_gemma":[0.9923214,0.002383847,0.0005881999,0.003119455,0.001510355,0.000002972017,0.000005385833,0.00002764636,0.00004076304],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1861405,"threshold_uncertainty_score":0.5519487,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2094962451","doi":"10.1007/s10067-005-1157-y","title":"A randomized unblinded trial of cyclophosphamide versus azathioprine in the treatment of systemic sclerosis","year":2005,"lang":"en","type":"article","venue":"Clinical Rheumatology","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":181,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary; University of Alberta","funders":"Arthritis Society; Canadian Rheumatology Association; University of Calgary; Scleroderma Foundation","keywords":"Medicine; Azathioprine; Cyclophosphamide; Rheumatology; Randomized controlled trial; Internal medicine; Multiple sclerosis; Physical therapy; Chemotherapy; Immunology; Disease","retraction":null,"screen_n_in":null,"score":{"opus":0.100036176818296,"gpt":0.3790765538264038,"spread":0.2790403770081078,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001762104,0.0001831206,0.002333119,0.0001219482,0.0000224157,0.000003469169,0.0001742663,0.0003616281,0.00006595719],"category_scores_gemma":[0.002750989,0.00009861575,0.0008047592,0.0002637053,0.0005015121,0.00002046612,0.00001908891,0.0001581674,0.00002872362],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005644919,"about_ca_system_score_gemma":0.0002068897,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001632917,"about_ca_topic_score_gemma":0.0000180187,"domain_scores_codex":[0.9956438,0.0009687356,0.002600355,0.0002968683,0.0002604073,0.0002298588],"domain_scores_gemma":[0.9919916,0.006527402,0.0007109861,0.0005580334,0.0001052413,0.0001067031],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9643144,0.004653369,0.01376465,0.0001173405,0.0006507285,0.000009483829,0.0007821256,0.00002036718,0.0001155765,0.00116471,0.0001438264,0.01426339],"study_design_scores_gemma":[0.9897925,0.002611745,0.003988195,0.001707454,0.0005950768,0.00005350392,0.0005257166,0.0002279443,0.0002630076,0.0000352738,0.0001115532,0.00008804879],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9818814,0.01395394,0.00001107765,0.0008526854,0.0009617427,0.001918107,0.000005677775,0.00002172473,0.0003935785],"genre_scores_gemma":[0.945568,0.05397666,0.00009750944,0.00005986894,0.00008113881,0.0001601456,0.00001022593,0.00001342082,0.00003306474],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04002272,"threshold_uncertainty_score":0.4021434,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2158781546","doi":"10.3899/jrheum.081284","title":"The Localized Scleroderma Skin Severity Index and Physician Global Assessment of Disease Activity: A Work in Progress Toward Development of Localized Scleroderma Outcome Measures","year":2009,"lang":"en","type":"article","venue":"The Journal of Rheumatology","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":181,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":true,"about_ca":false},"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; Cardiff University; University of Pittsburgh","keywords":"Medicine; Intra-rater reliability; Intraclass correlation; Dermatology Life Quality Index; Inter-rater reliability; Quality of life (healthcare); Erythema; Physical therapy; Severity of illness; Reliability (semiconductor); Scleroderma (fungus); Surgery; Internal medicine; Disease; Confidence interval; Psychometrics; Pathology; Rating scale; Psychology","retraction":null,"screen_n_in":null,"score":{"opus":0.03090790652181059,"gpt":0.3158056981170888,"spread":0.2848977915952782,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001234854,0.0002281384,0.00104107,0.0001050411,0.0001154024,0.00001645301,0.0002881415,0.000127531,0.000004038382],"category_scores_gemma":[0.0001598237,0.0001210666,0.0001794427,0.0003842582,0.0004639555,0.00008077861,0.00007726839,0.0003300957,4.329327e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001275715,"about_ca_system_score_gemma":0.0006549568,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005088239,"about_ca_topic_score_gemma":0.00002110355,"domain_scores_codex":[0.9969497,0.0006410966,0.001258912,0.0001595122,0.000672803,0.0003180199],"domain_scores_gemma":[0.9979009,0.0002459846,0.001107738,0.0003052868,0.0002219948,0.0002181143],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.007256065,0.0008066797,0.9004984,0.0002197545,0.0004538688,0.00001166666,0.0008796039,0.0001024054,0.0002675234,0.00009201306,0.0001274017,0.08928455],"study_design_scores_gemma":[0.005095638,0.0001853467,0.9899358,0.002475259,0.000240402,0.0001939522,0.0006821671,0.0005625552,0.0002648843,0.00018712,0.00005544031,0.0001214035],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9892343,0.005963732,0.001057751,0.003109146,0.0001509956,0.0004336732,0.000004229536,0.000009918101,0.00003628212],"genre_scores_gemma":[0.9980416,0.001426858,0.0003509212,0.0001509388,0.000009388922,0.000006219313,0.000001024332,0.00001070275,0.000002399877],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08943736,"threshold_uncertainty_score":0.4936951,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}